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ABSTRACT
The heavymetal cadmium is a widely distributed naturally occurring toxic
element.Zincand cadmiumhavestrikingphysicalandchemical similarities. Thefact
that they compete with each other for the same metenctbloneln makes their
biological interactions very likely. In this study the effect of zinc deficiency on
potentiating the pathologiceffects of cadmium on the immune system and the
kidneyswere studied, Four week old C57BL6 matemice werefed zinc deficient diet
(Zn 1 ppm) for 4 weeks, then cadmium50 ppm was added to the drinking water,
and after 3 weeks they were fed a regular chowdiet. Animalswere sacrificedat 0,
3 and 6 weeksafter cessation of treatment.In other groups,50ppm zinc wasadded
to the regular chow dieL
The number of IgM and IgG antibody formil1g cells in the spleen was
significantly lower after treatment with zinc-deficient diet compared to nontreated
controls. Concurrent administration of cadmium antagonised that reduction.
Proliferative response of spleen cells to the T cell-mitogen, phytohaemagglutinin
decreased aftertreatment withzinc-deficientdietandcadmiumadministrationtended
to increase it. The number of CD4+ and COSt cells was decreasedafter treatment
with Line-deficient diet and a further reduction was observed after concurrent
cadmium administration. Natural killer cell activity in the spleen decreased after
treatment withzinc deficient diet. Concurrent cadmium administration causedmore
suppression.
Simultaneous Treatment with zinc deficient diet and cadmium did not alter
spleen, thymus and kidney weights and lymphocyte count. However, lymphocyte
· ii i-
count in blood collected from the right atrium of the heart was significantly
decreased in animals treated with zinc-deficient diet.
On electron microscopic examination, kidneys of cadmium-treated mice
showed ultrastructural alterations in the proximal tubuhr epithelial cells. However,
animals treated with low zinc diets showed cellular degeneration mainly in the
cortical area of the thymus. Zinc concentrations in the kidney tended to decrease
after treatment with zinc-deficient diet. Cadmium concentrations increased after
treatment with zinc-deficient diet and further increase observed after concurrent
cadmium administration.
INDEXING KEY WORDS: Cadmium, Zinc, Cellular Immunity
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CHAPTER1
Introduction
I) Trace Elements
Until the beginning of the 20th century, It was not possible to measure the
precise concen trations of many mineral elements that are p resent in living tissues
in minute amounts. Therefore, they were described as "traces" and the term trace
elements emerged to identify them. Although they ca n now be estimated Inbiological
materials with considerable precision and accu racy, the design ation "trace elements"
has remained in popular usage.
As early as 1800, Copper was shown in snails to extst in combi nation with
blood proteins, and copper-containing pigment, hemocya nin, was found to behave
as a respiratory compound in various marine organisms. A french botanist published
rema rkable observa tions on the iodine content of soil, water and food and
concluded that the occurrence of goiter in man was associated with a deficiency of
environmental iodine (Chatin 1870).
It has been diHicull in the last several decades to find a useful classification
for trace elements or to draw a comp letely satisfactory line of demarcat ion between
those so designated and the so called "major" elements. Even the discovery of such
substances did root rapidly attract enough scientific curiosity to stimulate studies of
possible wider significance.
A perma nent and logical classification of trace elemen ts may be based on
chemical characteristics . At the present time, more than 90 naturally occu rring
elements are known to exist. Out of these, 15 are known to be essential or beneficial
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elements for humans or an imals. These are : arsen ic, chromium, coba lt, copper,
fluor ine, iodine, iron, mo lybdenum , nickel , selenium , sili con, tin, vanadium,
manganese and zinc (Mertz, 1981 , Chandra, 1983) . The essent iality 01 such
elements is establ ished when a further reduction below the range of to lerable level
resu lts in a consistent and reproducible impairment of a physiological functio n. A
com mon prope rty share d by most essenlia l elements is that they exist and funct ion
in the living t issues at very lowconcentrations; some are exp ressed as parts per
million (ppm) othe rs as parts per b illion (ppb). Practica l importance in terms of
toxici ty of the trace elements is totally unrelated to essent iality. Some essential
elements such as manganese are not being of any as-yet -known concern 10hum an
nutrmcn, whereas , oth ers such as zinc affect both human nutrition and immunity.
Other trace elements referred to as "non-essential", for examp le, cadm ium,
arsenic or mercury, do nOIappe ar to serve any vilal function in man, although recent
obse rvations in ruminants do point to some biolog ical role. The existence of such
elements in the living org anisms acqu ired by inhalation , ingestion or injection even
in small to mo derate amoun ts presents potential hazards thus they are labelled
't oxic" elements .
Essential trace elemen ts serve a wide range 01 funct ions. They may act as
catalysts in enzyme systems in cells that vary from a weak ionic effect to highly
specific associat ions in metall oen zymes. Such functions are physio logically
maintained by specific protei ns (e.g . transferrin and metajothoneln) thai regulate
trace element absorption, d ist ribution, metabol ism and excret ion and also carry them
to specif ic sites wher e recognit ion and disso ciation lakes place (Chandra and
Dayton , 1982).
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The essentialfunction of tract! elementsin the defence mechanisms against
microbiological, chemical, viral and oxidative insults has become well recognized
(DiplockA. 1981• Chandra and Dayton, 1982· Bendich and Chandra 1990) linking
deficiencies of some trace elements not only with risk of infection but also with
chronic degenerativeand neoplastic diseases.
Deficiencyof some of the essentialtraceelements tends to be common world
wide problems. Deficiency is defined as 'a slale in which the concentration of an
essential nutrient at lts sites of action is inadequate to maintain the nutrient-
dependent function at its optimum level". Since the number of functions that are
accepted as criteria of nutritional status increases every day with every new
discovery, this definition is considered as a wide ranging spectrum of clinical and
metabolic disturbances. A new proposal has been submitted (Mertz, 1986) that
characterizes the gradual changes that occur as a result of suboptima l intake of
nutrient supplies in diet and environment into four phases: £b.as..eJ, changes in the
metabolism of the element itself as a compensation for subopt imal Intake during a
certain period of time so that no change in biological structure or function Is
detected. This phase may revert back to normal status with an increasing intake of
the nutrient.~, "compensated metabolic phase" is characterized by an
impairment of certain specific biochemical functions such as trace element -
dependent enzyme activities.~ "decompensated metabolic phase",
characterized by the appearance of defects In functions Important for health, such
as: metabolic, immunological, cognitive, emotional, developmental and those related
\0 work capacity. Signs and symptoms of this phase are not clinical and are
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detected only by specialized tests.~ ' clinical phase- characterized by
appearance of disease and with increasing severity of deficiency , by death.
Iron is an essential element that acts as a main component of oxygen
carrying prot ein haemoglobin , a deficiency of which leads to anemia especial ly in
high risk persons, such as: infants, adolescents, elde rly, pregnant and lactating
women. Iron is also essential for optimumimmune responses, so that its deficiency
impairs T-cell function , lymphocyte proliferation, response to different mitogens.
macrophage migrallon inhibition teeter and delayed cutaneou s hypersensitivity
responses (Chandra, 1983). Zinc is an essential co-factor in many metalloenzymes
and, lts severe deficiency is seen in the inherited malabso rption syndrome,
acrodermatit is enteropethca,wh ich is characterized by frequent b acterial, fungal and
viral infections. Zinc is also important for the integrity of the immune system, its
deficiency resulting in rapid and marked atrophy of the thymus and loss of its activity
(Chandra and Au 1980 · Dardenne et.al., 1984).
Copper is a key regulator of lysyl oxidase activity. Reduction of its availability
produces neutropenia and impa ired reticuloendothelial function and antibody
response to heterologous red cells (Prohaska et.el., 1983 - Vyas and Chandra,
1983).
The subject of interacti ons between trace elements with other dietary
elements has attracted the atten tion of many Investigators (The Ta sk Group on Metal
Interaction, 1978 • Levander and Cheng 1980 • Hoadley and Cousi ns, 1985).
Recently the implications of these interactions on the immune system have started
to emerge (Chowd hury and Chandra , 1987).
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Zinc and Cadmium are two recognized membersof the trace elements group,
that have similar physical and chemical properties because they both belong to the
second group of the periodic table. This makes them compete for the same
metallothlone'n. However, zinc is an essential element while cadmium is a toxic
metal.
In a subsequent section 01this chapter the metabolic and biological features
of zinc and cadmium will be discussed with particular emphasis on their effect on the
immune system.
II) Zing
Zinc was clearly established as an essential element for high forms o f plant
life more than 150 year back, (Somner and Lipman 1926). Before that, in the
previous century it was on ly considered essential in the nutrition of th e fung us
Aspergillu s niger.
Considerable progress towards clarificationof thepract ical impo rtance of zinc
in human nutrition followed the studies of Prasad and co-workers (1961) which
provi ded th e first evidence for the occurre nce of nutritional zinc deficiency in man.
The essentiality of zinc has been proven to be for almost every organ system of
the body as it is widely d istributed in the tissues. An adult booy is estimated to
co ntain 1.4 - 2.3g of zinc, 20% of the total body content is present in the ski n and
cons iderable proportions exist in the bones and teeth. Adult human b lood conta ins
less than 0.5% of the total body zinc (National Research Council, 1978) 75-88% is
in the red cells, 12-22% in the plasma and less than 3% in the leukocy tes and
platelets.
Zinc metabolism:
The mechanism and contro l of zinc absorption is not fully understood.
Con flicting results from experimental studies in vitroor in vivo mayarise in pa rt from
differences in experimental conditio ns, as zinc absorption appears to be readily
influenced by a wide variety of host and environm ental factors (Solomo ns and
Co usins 1984) .
In rat s, zinc is absorbed main ly from the duodenum, jejunum and ileum with
very little being absorbed from Ihe stomach (van Campen and Mitchell , 1965-D avies
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1980 ). Intestina l absorptio n o f zinc h as been proposed in fo ur phase s (Cousins,
1982): .first. u ptake by the intestinal ce lls, the details 01 this me chanis m have not
been defined yet;~, movement through the mucosalcell;JhirQ, transferto the
porta l circulati on, this appears to be a carrler > mediated process which probab ly
involves Interaction with the me tal in a che!ated form. The ava ilability of zinc for
uptake by the brush border may be determined by factors such as pH and its
relative distribution among small ngands and larger molecules withIn the intestinal
lumen. Thetransfer of zinc from themucosal wall to the porlal circulation is slower
than the uptakeandaccumulation within thecell andappears10 be Ihe rate limiting
stepin absorption Inrats (Davies 1960). In humans, at low zinc levels, mu ch of the
availab le suppiy is Iransported to lhe plasma, but as the zinc content increases,
less is taken up into the bOdy; .!Q.lJ.O!l, secretion of endogenous zinc back Intothe
intestinal wall. To studythe mechanismsof zincabsorption in animals previouslyfed
a ro c-adequate or zmc-deficlent diet, Steal and Cousins (1985) used a vascular
perfusion preparation in rats that included most of theintestine,From 1em distal to
the bileduct10the ileocecal valve, theyfound that zincebsorpnon(transfer fromthe
lumen to portal circulation) was saturable in bot h groups and its uptake was
increased by zinc deficiency. Zinc depleted animals alsoshowed a more rapid rate
of absorp tion at all lumenzinc concentrations and highercytosolic concentrations
after zinc perfusion, suggesting that enhanced uptake, rather than increased
basolateral transport may account for some of the differences in absorption rates.
Absorbedzinc iscarried from theintestineto the liver in the po rtal circulation
bou nd to albumin (Smith et.et, 1979). The liver extracts about aooJo of the zinc
ente ring the hepatic venous supply and releases it back to the blood . Circu lating
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zincIscarriedby highmolecular weightproteins lntovarious eerahepanc tissues in
whichtherearedifferent ratesofzincturnover(AamOdt et.al., 1979). Themostrapid
accumulation andturnover ofretalred zinc isseeninthepancreas, liver, kidney and
spleen (McKenney eta, 1962). However, zincuptakebythecentralnervoussystem
and the bonesis relatively slow, andit remains firmlyboundlor longperiods. Zinc
enteringthe hairalsobecomes unavailable to the ttsSU8Sandis lostas thehair is
shed.
Theliver is1hemajororgan involved inzinc metabolismasit containsvarious
binding components of different molecular weight in proportions that vary with
differentzinc levels (Mason, at. aI., 1981). Metallothioneinhas an integral role in
hepatic zinc metabolism. It isa lowmolecularweight proteinthat isregulated in the
liverunder the controlofdietaryand hormonal signals andits synthesis is iflditectly
stimulatedby glucocorticoids, catecholamines, effect of zinc transport into the
hepatocvtes, stress,acuteinfectionand shock(Etzeland Cousins, 1981• Brady and
Halving, 1985 - Disilvestro andCousins, 1984 - Oh, et.et, 1978). Thesynlhesized
metaliothioneinbindstoheavymetalsand isdegradedwithahall-Iileof 18-20hours.
The degradation ratemay beincreased by low-zinc status(Disilvestro and Cousins,
1983).
In thehealthyadult human, about 90% of zincexcretionoccurs in the feces
(Weigandand Kirchgessner, 1980) (Bunker,et.al., 1982) andthe remainder 10%in
the urine, sweat and skin. Fecal excretion includes both unabsorbed dietary and
endogenouszinc. Endogenous fecal lossesarisefromthezincthatissecretedinto
thegutfrom1hebodyandisnot subsequentlyreabsorbed,andthisvariesaccording
to the balancebetween trueabsorption andmetabolicneeds. The aClual amountof
endogenous zinc excretion from human and animals de pends on zinc intake and
status. In humans, it may range from < 1mg to se veral mill igrams daily (Matseche,
et.al.,1980).
Zinc excretion in the urine ranges betwee n 300 to 500 ug / day (Hambidge,
1983). Th is level va riesacco rding to dietary intake of zinc adequate or zinc deficient
d iet, rena l tubular function, and a lso catabolic states suc h as severe burns, majo r
surgery or trauma. However, urinary exc retion o f zinc may be above nor mal as in
the case o f alcoho lic cirrhosis or administ ration of chelating agents such as EDTA
(Prasad, et.aL, 1965) (Spencer an d Rosoff , 1966).
Bio logical function of zinc;
The select ive prope rty related to zinc bio logical functions evolved from its
ability to fo rm stable complexes wi th the side chai n of proteins. Zinc is an essent ial
comp onent of different enz ymes in human and anim al tissues. Ca rbonic anhydrase
was the first zinc metalloenzym e to be identi fied (Keilin and Mann , 1940).
Subseque ntly, its involvement was recognized in alcoho l dehydrogenase, alkaline
phosphatase , pro carboxypeptidase and in nucleic acid m etabolism enzymes such
as DNA polymerase, RNA polymerase, reverse transcriptase and nucleoside
phosphorylase (Ueb erman. etal. . 1963).
Zinc has als o an important structura l role in the retina as it contains the z inc
metalloenzyme, retinene red uctase which is required fort he reconstitution of retinen e
(Vitamin A aldehyde) dur ing the rhodopsin cycle (Harper, et.al., 1979). If relate d
enzymes fromdiffe rent species are included , then over200 zincmetalloenzymes are
now on recor d (Vallee, 1983) (Prasad, 1984). Zinc supplementation may be effective
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to mainta in normal concentrations of vitamin A in the plasma as it is required for
mobilization of vitamin A from the liver when its concentration in the plasma is lower
than normal and unresponsive to vitamin A therapy.
Zin c forms complexes with insulin wh ich makes it possible for Ihe crystalline
zinc insulin molecule to increase the duration of insulin action when given by
injection. Zinc insulin complexes are also present in the (6)B cells of the pan creas
and there is evidence suggesting that its existence is important for storage and
release af insulin as required.
Many autho rs have addressed the importan t structural role of zinc in for ming
rnercaptlde a with the thiol qroeo of proteins, in linking the phosphate moiety 01
phospho lipids and its interactions with the carboxyl groups of sialic acids or proteu s
on plasma membrane reSUlting in a change in its flu idity and stabilization (Chvapil,
1976).
Substantial quantities of zinc are essentia l for deoxyribonucleic acid (DNA)
and ribonu cleic acid (RNA) molecular synthesis (Hambidge et.al., 1986). It stabili zes
the three d imensional structure of DNA binding doma in to some regulalory proteins
involved in gene expression (Kadonage et.el., 1987). Zinc-deficiency alters plasma
membrane functions and nucleic acid metabolism . In animals, the incorporation of
labelled thymidine into DNA was impaired a few days after starting a zinc-deficient
diet (srasa d, and otenees. 1974).
Zinc deficiency and immunity
The import ance of zinc in the development and maintenance of the immune
system is now w;dety accepted. Prasad and co-workers first recognized zinc
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deficiency in 1961. Absolute deficiency of dietary zinc is uncommon in human or
animals except under experimental conditions. Relative deficiency has been n oted
among child ren of low income families (Hambidge , et. at, 1976), institutional ized
individuals, elderly (Roebothan and Chand ra 1990) and pregnant teenagers
(Sandstead, 1973).
The pathogenesis of several diseases such as sickle cell anemia, renal
disease, alcoholism, certain gastrointestinal disorde rs, burns and the geneti c
disorder acrodermatitis enteropathica can create deficiencies in zinc (Chandra an d
Dayton, 1982) (Good. and Fernandes. 1979).
Clinica l manifestations of zinc:deficiency vary with different zinc serum levels.
These may include: bullous-pustulardermatitis, alopecia, diarrhea, mental
disturbances, male hypogonadism, poor appeti te, decreased taste acuity, abnormal
dark adaptation, poor wound healing, anergic response to skin sensitization and
recurrent infections due to distorted cell mediated immunity (Hambidge et.al., 1986).
The effect 01zinc deficiency on immune function havebeen well characterized
(Chandra, 1980 ) (Fraker et. et. 1982) (Tapazoglou et.al., 1985) (Chandra and Purl
1985). Zinc deficiency affects mainly cell mediated immunity in man and laborato ry
animalswith associated loss of the general lymphoid tissue . The thymus in particu lar
is affected mo re otten than other organs in the body (Fraker et.al., 1977) (Chan dra
and Au, 1980) . Althoug h a persistent severe zinc deficiency state will eventually lead
to atrophy of the entire organ, there is preferential loss from the cortex and thymus
dependent areas of peripheral lymphoid tissues .
The critical role of zinc in Iymphocyte funetion and the specific mechanism(s)
underlying the thymic atrophy associated with zi nc deficiency is as yet unclear. Good
- t2-
and associates (1982) suggested that decreased activity of terminal
deoxyribon ucleotidyl transferase as zinc cont aining DNApolymerase whiChis ne arly
exclusive to the thymus and immature thymocytes (Mcca flrey et .ef., 1973) wi ll lead
to an arrest in the growth , division and d ifferent iation of preccrso- cells into
immunoco m petent thymOcytes. This theorymay eccoca for the lX'lique sensitivity
of the thymus to zinc deficiency. As a re sult, lymphop enia, alterations in the
proportions of T-cea lymphocyt es a nd subsets (helper{inducer and
suppresso r / cytoto xic) and mononuclear macrop hages occur. Furtherm ore,
lymphocytes from zinc-deficient sub jects o r animals show reduced blastog enic
response to 'r-cell mrooe ns phytohemagglutinin (PHA) and concanavalin A (Con
AI·
A critical role 01zinc in normal 'r-ceufu nction is provided by the effect of zinc
deliciency o n delayed type hypersensitivity (DTH) responses (Fraker et.al., 198 2).
Adult mice fed zinc -deficient diet and, subsequently , percutaneously sensitized with
dinitronooro benzene (DNFB) gave significantly lower OTHresponses compa red to
both pair fed andad -libitlHTlcontrol mice with T helpe r cells. In the same experiment
repletion of the zinc·d eficient miceresulted in completely normalized OTH responses.
Similar observ ations have been noted in hu m an clin ical Meralure, depressed OTH
responses with severe zinc deficiency and po sitive responses alter zinc
supplementation. Such responses have be en seen in ca ses of acroderm anis
enteropath ies (Chandra, 1980), prolonged hyperaumentencn with inadequate zinc
(Allen et.al. . 1981) ob esity (Chandra and Kutty, 1980) (Rodin and Goldman , 1969)
and in cases of Down's syndrome in which patients are known to have increased
susc eptibility to infect ions and low serum z inc for un clear reasons. Bjorksten and
- 13-
associates (1980 ) were able 10cor rect mu ch of the Immune abnormalities witho ra l
zinc supplementation, thus confirmlng the nat ure c t the abnormal ity and its
relationship to zinc deficiency.
The impact of zinc deficiency on hurmora l immunity andantibody production
is much less unclear. Z inc has been considerdd to bean effective s-eel activator as
well as be ing ca p able of acting synergb;tically with B-cell milogens (Cunningham·
Rundles et.al., 1980). Other inv€stig5IOfS found th at B-cell mitogenesis is unaffected
by zinc deficiency in vitro (ZanZonico et.al., 1981 ).
Zinc depri vation reduces primary (lgM) and se condary (lgG) antibody
responses to heterologous antigens. In 1986, Fraker et.al. suggested that ztnc -
deficient mice prod uced 40% as many 19M and IgG plaqu e forming cells (PFC) p er
spleen in response to sheep red blood cells (S A Be), a T-cell-dependent antigen ,
compared to adeq uately fed mice. In the same e xp eriment , the ratio of T-ce as to B ·
cells was unaltered In the zinc-deficient mice and there was nearly double th e
proport ioo of B-cells be aring high amounts of surface IgM . These deta suggestin g
that augmented in vitro responses by splenocytes from zinc-delicient mice to
mitogens thought to stimulate the more mm a ture B·ce lls (dextran sulfate an d
lipopolysaccharid es), ind icated that a greater proportion of irTrnature B-cens mig ht
be accum ulating in the spleens of the zinc-defic le nt mice (Fraker, 1977).
Natural killer cell (NK) activity is also affecte d by suboptimal Intake of dieta ry
zinc or in pat ients receiving total parentera l nutri t ion with out zinc suppleme ntatio n .
A significant depr ession 01 NK celt activity was demonstrated in zinc-d eficient
patients with sickl e cell anemiaas compare d to control sub jects (Tapazogl ou, et.el.,
1985).
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l ack of zinc is especially harmful to the b~ utero development of the immune
response. Stud ies in mice have shown persistent states of immunodeficiency in the
ofisprlng that can even be transferred to subsequent generations (Beach, et.al..
1982).
The critical role played by zinc in function al neutrophil ac-ety has been
reviewed. As a result of zinc deficiency, actual intracellular quantity is reduced
(Chvapil, 1976) and chemotactic response of po lymorph onuclear leukocytes is
reduced which can be corrected after replenishment (Weston, et.al., t 977).
Excessive zinc inteke by healthy adults caused significant impairment of
polymorphonuctearfunctlon togetherwith reduced lymphocyteactivity and response
to mitogens. The theory which has been proposed by Chandra (1984) is that altered
lipid profiles in the blood and leukocyte membranes were responsible in part for the
immunosuppress ion associated with zinc excess. Other possible mechanisms for
this finding Include changes in membrane fluidi ty, interaction with copper and
alterations in calciu m flux. Duchateau, et.at.(1881) found that substantial doses o f
zinc (220mg tw ice daily) in immunosuppressed and normal elderly subjects
Increased the number of circulating r-ccne, and improved skin reactivity and the
antibody respon se to tetanus toxoid. These data sugg est that the pretreatment zinc
status and metabolic state have an important effect on the utilizationof zinc and its
effect, beneficia l Of adverse, on immune responses .
In spite of the extensive studies that started in the early days of this century ,
the impact of zinc on immunity is not fully understood . Several hypotheses have
been put forward and some of these havebeenproven experimentally. Experiments
suggest that the essentiality of zinc as a co -factor for a variety of melalloenzymes
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that are essential for cellular multiplication may result in deficiency of cellular
multiplication and decreased number of T· and B-cells. Other exper iments suggest
that zinc is an essential co-teeter for thymulin (one of the putative thymic hormones),
and its suboptimal intake decreases thymic hormone activity and, subsequently
leads to adverse immunological effects (Chandra, 1985) (Dardenne, et.al., 1984).
Recently, In acqu ired immune deficiency syndrome (AIDS), it has been suggested
that decreased zinc saturation may be responsible in part for the reduction of the
thymic hormones and subsequent immunologica l defects (Farbis et.al., 1988).
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III) .Q2Qmium
The hea'.'j' meta l cadmium (Cd) is a widely distribU1ed, natu rally occu rring
toxic element. At birth, cadm ium is virtually absen t from the human body. Thereafter,
its concentration tends to Increase gradually unlit age 50. Beyond that age the levels
of renal cadmium remain essent ially constan t or decrease (KJelistrom , 1979). The
total body burden of cadmium in a healthy mlocie -aqed person varies from 5·20mg
(Kowal et.at, 1979) (Vahterm, 1982), with large concentra tions in the liver and the
kidney and minute amounts distribU1ed in other tissue s including testis, lung,
pa ncreas, spleen and various endocr ine organs.
In 1942 Nicaud, et.al. report ed an unusual number 01 patients with severe
osteoporosis, pseudofractures and associated impairment 01 general health in a
group of alkaline accumulator factory workers , and cadmium was suggested to be
the causative agent. A few years later Friberg, 1950 repo rted an unusual number of
cases of lung and kidney damage among worke rs in an electrica l battery plant
where they were exposed to cadmlum-odde.
The grea test concer n over cadm ium pollution was triggered by Haqlno,
(1957) from Japan who reported that cadm ium poison ing is not restricted to
ind ustrial workers only, but load contamination can constitute a health hazard to the
generai po pulation. In areas polluted by cadmium, a high prevalence of proteinuria
was noted, but in other areas the exposure was high enough to cause severe bone
diseas e, the Itai·ltai disease (Hagino , 1957).
Epidemiological obse rvations an d laboratory experiments have underli ned the
importance of cadmium as a toxic agent and focussed light on the lmpo rtence of
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other nutrients such as zinc, iron and calcium in modifying the metabolism and toxic
effects of cadmium in man and animals (Fox, 1979).
Exposure to cadmium :
Cadmium is widely distributed in the environment. Human exposure occurs
mainly through inhalation and oral intake.
In the past 30 years industrial use of cadmium has Increased its level in the
atmosphere (Fleischer et.al., 1974) where it contaminates rain water, deposited on
tend and natural waters, and subsequently gains entry to the food chain of man
and animals. Thus, food is normally the major source of cadmium for the average
person.
In 1979 Harvey and co-workers reported in England that a small population
in a Somerset village were exposed to unusual levels of cadmium through
consumption 01 vegetables grown in cadmium contaminated garden soil. The
cadmium was brought to the surface from a nearby zinc mine, and contaminated the
soil throughout the village (Harvey et.at, 1979).
Cigarette smoke is an additional source of cadmium, espec ially for heavy
smokers . The relationship between smoking and cadmium levels in the kidneys,
liver, adipose tissue and lung have been demonstrated in a study of smok ers and
nonsmokers (Mussalo-Aauhamaa et.al., 1986). A higher body burden of cadmium
has also been found in smokers after analysis of necropsy materials (Hahn et.el.,
1987). Another study that was carried out on pregnant women who smoked,
demonstrated a significant elevation of cadmium levels in maternal blood, placenta
and cord blood (Kuhnert et.el., 1982).
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Since little 01' no recycling of cadm ium OCCUI'S, the amount enter ing the
environment roughly equals the amoun t prod lXed or used. This steady
accumu lation in the environment is of considerable concern when estimating
cadmium expos ure.
Health Effects of Cadmjym :
Data suggestingthat cadmium might be an essential element are very funited.
In 1976 Schwarz andSpallholz reported a growth support ing effect 01cadmium in
rats, but no confirmatory report s have analyzed these find ings .
Cadmium is toxic to Virtually every system in the hu man or animal body ,
whether ingested , injected or inhaled. There are large differences between the
effects of high, single exposures and of chronic exposure to smaller doses of
cadmium. Present data sugges t that the toxicity of cadmium is possibly determined
by the capacity of the tiSSUdS to synthesize rret allomlonens.
Vas t lITerature on various aspects of cad mium effect on general health has
been pu blished but is of limited value in evaluation of human or animal health.
In humans, inhaled cadmi um can produce active bronchial and pu lmonary
irritation and sometimes fatal edema and shock (Stanescu et.al. , 19n). Such
instances may occur in workers involved in industrial processes like welding ,
smelting or soldering, where cad mium is heated at a very high tempe rature and
inhalation of cadmium-oxide fumes occurs.
Oral exposure to cadmium predom inanlly produc es ga strointestinal reactions .
In Sweden , Nordberg et.al ., 1973 reported on some school children who had
ingested fruit juices from a vending machine which had a caoncm-prateoreservoir .
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Toxicity symptoms appearing minutes after ingestion, included, nausea, vomiting,
salivation, abdominal cramps and diarrhea.
In animals, single injections of high cadmium doses have a specia l impact on
the reproduc tive organs and the nervous system with minor effect on other organs.
Gabbiani, et.et, (1974), reported necros is of the sensory ganglia after injection of
high doses of cadmium, while Parizek, (1983) observed test icular and placental
necrosis and suggested that testicular necrosis can also be induced by relatively low
doses that do not damage ot her organs.
l ong term exposure to cadmium affects almost all organs in the body. Kidney
is the primary organ to be affected. Renal tubu lar proteinuria occurs regardless of
whether exposure is oral, by inhalation or by repeated injections. Data on the
mechanism of kidney damage by cadm ium and relation to metallothionein have been
revtewed by many authors (Squibb and Fowler, 1984) (Piscator, 1984).
Cadmium mainly damages the proximal tubu les, resulting in decreased
reabsorpt ion of proteins especially low molecular weight proteins like 82
microglobulin and lysozyme. Experimental animals treated with cadmium
demonstrated mitochondrial abnormalit ies and electron dense materials (probab ly
cadmium - metallothionein) in the proximal tubular cells (Borgman and Chandra,
1987).
The mechanism by which renal toxicity develops during cadmium toxication
is still unclear. Many investigators believe that kidney damage is prevented as long
as the kidney can produce enough mete'lothioneln. Beyond that stage , the non-
metallothioneo bound cadmium ions become very toxic (Norberg 1978 • Homiyama
and Nomiyama, 1982).
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The link between cadm ium and hypertension is not fully understood . It has
been observed tha t selenium. copper, and zinc may counteract the hyp ertensive
actio n of cad miLm. Data from several animal studies reveal that hypert ension can
be induced on exposu re to low dos es of cadmium (0.1 - 2 ppm) in drink ing water
while hypotension will occur if the dos es exceed this range (Perry and Erlanger ,
1974) (Kopp ete t, 1982).
In huma ns, some authors have suggested cadm ium induced hype rtension
(Schro eder eter, 1965 ) (SChroede r, 1974), while another grou p of scien tists from
Japan (Shigematsuet.at, 1979) couldnot provethe hypertensive effects of cadmium
when they conducted a study on a very largesampleof population living in cadmium
pollutedareas.
Attention 10 the poss ible role o f cadmiu m in inducin g bo ne disease was
enhanced when a meeting was held in Japan in 1979 on cadmium induced
osteopathy (Shigematsu and Nom iyama, 1979). Most of the find ings obtained from
animal studies indicated th81 cad mium can induce osteomalacia or osteoporosis.
Mlneral disturbanceswhich are caused by renaldysfunctioneventually might be the
caus e of rena l stones or osteomalacia.
In humans long term exposure to cadm ium has not been known to increase
its concentration in the bone . ltai-Itai disease was an extreme example of
osteomalacia that affected middl e aged mUltiparous women with typ ical features 01
bony pa in, walk ing difficulty and spontaneous fractures (Friberg et.al., 1974).
Data about asso ciation betwee n exposu re to cadm ium and lung or pros tatic
cancer have been obta ined most ly from experimen tal animals . Rats exp osed to
cadmium chlorid e for 18 mont hs by inhalation had acquire d lung carc inoma
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(TaKenaka et.al., 1983) and injection of cadmium chloride in the prostate have
produc ed prostatic tumours (Scott and Aughey, 1978). The risk of acquiring lung
cancer in humans after exposure to cadmium depends on lte percentage in the
atmosphere as well as presence of other metals such as arsenic (Holden, 1980).
This confirms the report of Thun et.al (1985) who noted an increased risk of lung
cancer in cadmium smelter workers. However, other authors have noticed an
insignificant risk of rung cancer in alkaline battery factory workers (KJellstrom etal.,
1979).
Interpretation of studies on humans have been difficult. Some of the studies
have used small numbers of subjects while others did not take In consideration the
airborne concentration of cadmium compounds that might lead to cancer of the lung
or the prostate.
Damage of reproductive tissues such as gonads and uterus is considered to
be one of the most critical effects of cadmium. A single parenteral injection of
cadmium salts was reported to produce haemorrhagic necrosis of the testes
(Pariz.ek,1983), while in female rats, cadmium injection caused hyperemia of the
ovary, atresia of the follicles and features similar to toxemia of pregnancy (Furuta,
1978). Teratogenic effects of cadmium have not been identified. It has been
hypothesized that occupationally exposed women have offspring with lower birth
weights than in controls. Some workers have reported that cadmium may have a
role in the development of pregnancy induced hypertension (Chisolm and Handcrt ,
1985) but this report has not yet been confirmed.
Severalinvestigators havedemonstrated that high doses of cadmium induces
conqenitat developmental anomalies and fetal death in laboratory animals (Farm and
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Carpenter, 1968) (Ferm, 1971) (Chernoff, 1973) and low levels of maternal dietary
cadmium fed throughout gestation cause fetal growth retardation (Webster, 1978).
Placental transfer of cadmium has been investigated but with conflicting results. Early
studies lead to speculations that the placenta constitutes a barrier against fetal
cadmium accumulation (Berlin and Ullberg, 1963). A few years later Sonawane,
et.al., (1975) indicated that with intravenous administration in rats, cadmium chloride
crossed the placenta with relative ease. However, when cadmium chloride was
administered orally to pregnant rats fetal accumulation of cadmium was extremely
low (Ahokea and Dilts, 1979). Thus it is not known whether the embryotoxic effect
of cadmium is a function of the amount transferred to the fetus or an indirect action
on the embryo .
Cadmium and immunity
Cadmi um has the potency to interfere with the immune system (Kranje et.al.,
1983). Significant suppress ive effect had been observed on both humoral and
cellular immunity. The responses vary according to the species, route , dose and
time of cadmium exposure in relation to antigen challenge (Koller, 1980) (Muller
et.et, 1979).
Primary (lgM) and secondary (lgG) antibody responses were not altered after
antigen challenge of oral cadmium (25 • 5Omg) treated mice (Multer, at. aI., 1979).
These results were in contrast to those reported by Koller et.el., 1975. However,
Malave and DeAuffino (1984) claimed a 30% increase in the 19M 01cadmium treated
as compared to contro l mice, while Blakley (1985) found a decrease In responses
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with the same low oral doses . The same resu lts were obtained later by Borg man,
et.el., 1986.
The parenteral route of cadmium administration affected different levels of
antibody prod uction. Koller et.el. ~ 1976 report ed an increase in primary (lgM) and
secondary (IgG) antibody responses after injection of 0.15 mg of cad mium, but
when doses of 1.8 mg!kg body weight was injected. supp ressed antibody
respon ses occu rred due to direct B-ceUinactivation (Fujimakl, 1985).
The effects of cadmium on cell - mediated immunity have been reviewed by
many authors . Delayed type hypersens itivity was evaluated by Muller, et.al. (1978)
as this is a classical test for determination of cell-mediated Immunity. A gro up of
cadmium treated mice and a control group were sensitized with sheep RBC and
challenged by a single Intracutaneous foot pad inject ion of the same antigen . The
reaction was inhibited in cadmium treated mice in relation to the cont rol ones .
Inhibition was related to cadmium concentrat ion detected in the serum of the
animals. Another way of estimating cell-mediated immun ity Is evaluation of T and B
lymphocyt e function. Cadmium treated mice gave significantly higher response s to
T-cell mitogen , phytohemagglutinin (PHA) and concanava lin A (Con A). Similar but
less pronounced effects were observed by stimulating spleen cells with,
lipopoly sacch aride (LPS), a B lymphocyte activator (Muller et.a1., 1978) . Similar
results were obta ined by Malave and De Ruffino (1984) with increased T-cell activity
to PHA and Con A. However, a decreased response was observed by Gaworski and
Sharma (1978), and no change in responses was claimed by Wesenberg and
Wesenberg (1983). The variations and the conflicting results obtained from different
experiments might be due in part 10 using different strains of m ice as CSA mice were
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found to be high responders while C57 Bl /S mice are low responders to PHA or
Con A, and to different experimental protocols. Low responsivenessmight be a
consequence of the mbitory activity 01adherent cells (Malave, 1981). On theother
hand , variations in the procedure to evaluate IyrTllhocyte proliferalion could also
contribute to the differencesin the reported results.
Cadmium as an environmental contaminant alters antibaCterial defense
mechanisms (Fassett, 1975) (Gardner etet, 1977). This aheration seemsto be due
specially to an impairmenl of the function of phagocytic cels (Gardner et.al., 1977).
It was reported that in cadmium treated animals the phagocytic capacity of
maa ophages and polymorphonuclear leukocytes has been reduced (l oose et.al.,
1977). Also macrophage migration inhibitor factor was found to be suboormat
(Kiremidjan-Schumacheret.a t, 1981).Notonly areantibacterialdefensemechanisms
affected by cadmium treatment, but antiviral and antiprotozoal deferr~mechanisms
arealso affected, with generalizedillYTlunosuppression and increasedsusceptibility
to infections (ExCflet.aI., 1979).
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Interaction between cadmium and :line:
line is known as an essential element and cadmium as a toxic heavy metal.
Both have striking physical and chemical similarities that place them in group II of
the periodic table. The fact that they compete with each other for the same
metallothionein makes their biological interactions very likely, also raising the
possibility that cadmium toxicity can be treated or prevented by zinc.
In 1957 Parizek declared that the destructive effect of cadmium ion on the
testicular tissue can be prevented by administration of large doses of zinc. These
observations were confirmed by Gunn et.at (1961) and Webb (1972).
Petering et.al. (1971)could not prove that the prevention of cadmium induced
pathologica! changes by zinc may have been because cadmium had been orally
administered in small doses as opposed to other workers who had used it in large
parenteral injections. However, they agreed on the same principle of the
antagonizing effect between zinc and cadmium even at low cadmium doses. They
found that the growth rate of rats was markedly affected when zinc was given orally
in low doses (zinc:cadmium ratio 1:1), whereas there was no effect when zinc intake
was higher (zinc:cadmium ratio 4:1).
Cadmium and zinc interactions also appear to be involved in other biological
areas such as teratogenecity (Ahokas et. al. 1979). When pregnant rats were given
low drinking water levels of cadmium (0, 10, 100 ng/ml) during gestation it resulted
in a decrease of all maternal parameters throughout the period of pregnancy. Even
term fetal weight was significantly less than that of control subjects. Growth
retardation was a result of decreased cell division (DNA) and cell growth
(protein/ DNA ratio). Dietary zinc supplementation (5.0 ug/m l) of cadmium fed dams
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increased maternal food consumption, fetal weight, DNA, protein/DNA ratio and fetal
zinc levels.
It is well known that lack of dietary zinc results in severe impairment 01growth
and substantially increased protein and amino actd catabolism and urinary nitrogen
excretion (HsU and Anthony, 1975). The decreased feed efficiency observed with
cadmium may be a manifestation of zinc deficiency induced by competitive
interaction of cadmium with dietary zinc. This mechanism had an impact on
nephrotoxicity (Watanabe, et. at 1985), carcinogenicity (Gunn, et. at 1963) and
immunity (Ohowdnury , et. aI. 1987) where selective Immunotoxic effect of relatively
low doses of cadmium was prevented by large doses at zinc in drinking water. The
specific mechanism(s) by which cadmium decreases appetite and nutrient
metabolism requires further investigation.
In higher mammals such as man and horse, zinc concentration in the renal
cortex has been shown to increase on an equimolar basis with the increase of
cadmium up to a cadm ium level of about 50·70 ng/g . Above this level the increase
of zinc is less pronounced (Piscator, 1975 · Elinder, et. aI., 1977). In 1973Nordberg ,
et.al postulated that the increase of zinc is believed to be a compensation for the
increase of cadmium through formation of metallothionein which binds both zinc and
cadmium on a molar ratio of 1:1. Webb (1975) stated that after long term exposure,
about 78% of the cadm ium in the kidney and liver is bound to metallothionein. Three
forms of metallothione ln have been identified, one binding equimolar amounts of
cadmium and zinc, a second binding mainly cadm ium, and a third binding mainly
zinc. In large farm animals, the finding of an equlmolar increase of zinc with
cadmium in the renal cortex seems to indicate that it is the form of metallothionein
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which binds equal amounts of zinc and cadmium that is prese nt there. On the other
hand. the limited increase of zincdespite greater increases of cadmium in the renal
cortex of most laboratory animals might indicate that the forms of metallothionein
binding higher amount of cadmium are produced.
In experimental animals, cadmium exposure causes increases in hepatic and
renal zinc concentrat ions which occur at the expense of decreased zinc
concentration in other organs (Roberts et. at 1973). Other in vitro studies showed
that cadmium reduced the activity of several zinc dependent enzymes (Vallee and
Ulmer, 1972). This might explain the tubular proteinuria that occurs in chronic
cadmium poisoning , which was postulated to be due to decreas ed activity of certain
zinc requiring enzymes like alkaline phosphatase and leucine aminopeptidase, and
believed to be involved in tubular reabsorption of pro teins (Wachsmuth and 'torhorst,
1974).
It should be pointed out that the exposure potential for humans and farm
animals is usually quite different from that of laboratory animals. Laboratory animals
are usually given excessive doses of cadmium or zinc during a short time, while
humans have a low daily intake.
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CHAPTEAII
Rationale and Objectives
Cadmium, is a widely distributed, naturally occurring toxic element. With
increasing industrial use, polluto n of the environment and cigarette smoking, its
toxicity to humans has become a matter of worldwide concern . In moderate to high
doses, cadmium Is an immunosupp ressive agent and enhances susceptibility to
bacterial, protozoal and viral infections.
On the other hand, zinc is an essential trace element. lis deficiency was
thought to be exceedingly rare, but recently it has been suggested that milder lorms
of this conditio n are sufficiently common to be of potential public health concern .
This may. in part, be due to lncreasmq consumption of highly processed and refined
foods that results in loss of zinc.
Zinc and cadmium have siriking physical and chemical similarities. Both
belong to Group II of the periodic table and compete for the same metallothionein
in various tissues. Thus it was suggested that cadmium toxicity can be prevented
or ameliorated by zinc administration . Both toxicity of cadmium and deficiency of
zinc affect all systems of the body. Their impact an the immune system has been
extensively investigated in man and laboratory animals with variable results
depending on the dose, duration and route of administration of the two elements.
The principal objective olth e present study is to investigate the possible effect
of zinc deficiency on potentiallng the pathologic etfect at cadmium on the immune
system and the kidney of mice. The mouse was chosen as the animal model as it
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has a Vi~1I characterized immune system that closely parallels the human immune
system at all developmental stages.
prjmary Ob jective:
To study the effect o f a relatively low dose of oral cadmium treatment on
the immune system of zinc deficient mice.
1. To study the effect of cadmium on renal morpho logy ;
2. To study the effect of zinc deficiency on the immune syst em of
mice;
3. To study the lmmunop zahclo qlcel effect of cadmium on zinc supplemented
mice.
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CHAPTER III
Design of the Study
Treatment Schedules:
Male 5-6 week old C57BL/6 mice were used in the study. M ice were divided
into six experimental groups. Each group received a different treatment but housing
conditions were identical \n all groups .The design at the experiment is shown in Fig.
3-1.
.G!.QupJ: No treatment
~: Zinc deficient diet (Zn 1 ppm) for 4 weeks , followed by th e administration
at cadmium (SOppm) (cadmium chloride, No. 810064-34, 80H chemica ls, Toronto)
in deion ized distilled water for the next 3 weeks, and no treatment for the last 3
weeks.
fu2.Imlll: Same protoc ol as Group II bu t during the last 3 weeks, zinc (50 ppm)
(zinc chloride, No. Z.0150, Sigma Chemical Compan y, St. l ouis , Missouri) was
added in deionized distilled water.
.fuQua...!Y: No treatment for 4 we eks, nne (50 ppm) and cadmium (50 ppm ) added
to deionized distilled water for the next 3 weeks end no treatment for the last 3
weeks.
Group V : No treatment for 4 weeks, cadmium (SO ppm) added to de ionized distilled
water for the next a weeks , and no treatment lor the last 3 weeks .
£!:Qwl..Yl: No treatment tor 4 weeks , zinc deficient diet (1 ppm) + cadmi um (SO
ppm) in deionized distilled water for the next 3 weeks , and no treatment lo r the last
3 weeks .
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Treatment
HH zn deficient 0plus NoneCd (50ppm)
8 Zn (50ppm) DTI Cadmium 50 ppm
HE Zn (50ppm) Bplus Zinc deficient dietCd (5 0ppm) ( an 1 ppm)
I I
1111 111 11111111 1111
1111 I1111 111 111 1111
11111111111 11111111
1111111111111111111
11111I11 111 11111111
Time of killing 0 wk
Design of t he study
, wk 6 wk
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Animals were killed for examination at the end of each treatment period (4th,
7th and 10th weeks) these are termed 0, 3 and 6 weeks of observatio n respectively.
In each treatment period for all six groups , there were 8 to 10 mice, however, at 0
week, only 2 groups were sacrificed , because at that time period groups I, IV, V and
VI were identical, and groups II and III were identical as well. This desi gn aHowed
study of the eHects of zinc deficient diet on the immune system of mice before and
after receiving low dose of cadm ium. The no treatment group (Group I) provided
control data and baseline values.
Zinc deficient diet containing zinc 1 ppm was chosen as previous studies
have shown that the Immune system of mice was affected by such a diet after 4
weeks (Fraker, et et 1987; Fraker and Gershwin, 1986) . A low dose of cadmium
(50 ppm) and oral route of exposure were chosen as these are more akin to
poss ible human cadmium toxicity, Since cadmium has a long biologica l half life, the
study period was extended after cessation of cadmium treatment. Cadmi um was
used at a dose of 50 ppm as previous studies have shown that at this dose the
immune system of mice is affected (Borgman etal., 1986), but the animals in this
study did not show any cfinical mandestatlons of toxicity, as was also observed by
a previous study (Chowdhury et.al., 1987). Zinc treatment was chosen at a dose of
50 ppm because zinc and cadmium compete for the same metato thionein , and at
a-t identical concentration, II is possible that zinc may ameliorate the toxic effects of
cadmium.
Experimental proto col:
The experimental period was spread out between 6 to 10 weeks and the total
number of animals was 96.
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Mice from all groups were monitored for weight and food consumption once
a week at the same time and hour. Atter kiDing each animal, the kidneys , spleen and
thymus were weighed.
The total number of lymphocyt es was counted in the blood , spleen and
thymu s. Direct and indirect plaque - forming cen responses which assay 19M and
IgG antibody product ion respectively by spleen cells against sheep red blood cells
were measured. Proliferation respo nse of spleen cells to T cell mitogen
(phyto hemaglutinin - PHA) was also assayed. Number ofT cells and subsets (helper
and suppressor) was counte d by direct immunofluorescence staining by using
appropriate monoclonal antibodies . Natural killer cea activity was measured by
chromium release assay in iso lated splenic lymphocytes. Transm ission electron
microscopic examination of kidney and thymus sect ions were perlormed. Kidney
was analyzed for cadmium and zinc levels.
Detailed description 01 the animals studied, diet, hous ing, and laboratory
methods is given in Chapter IV.
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CHAPTER IV
Methods
4.1 Housing and feeding the mice :
Male C57BLj6 mice (Charles River Canada, Montreal, Q uebec) were
mai ntained in theAnimalCare Facility of the Facultyof Medicine, Memo rial University
of Newfoun dland.
In group I and V mice were hou sed singly in plastic cages with bedding while
in g roup II, III, IV and VI mice were also marked individually but in stainless steel
cage s with wire mesh bottoms to avoid mice treated with zinc deficie nt die t from
having an access to the bedd ing.
Distilled water wasprovided in plastic bottles with siliconizedrubber stoppers
and stainless steel tubing. rood pellets were placed in stainless stee l feeders. The
tem perature in the anima!rooms was controlled at 22.24oC, relative hu midity at 45-
55% and lighting hours at 0800 to 0200. Standard guidelines for care and use of
exper imental animals were followed throughout (Canadian Council on Animal Care,
198 4) and the protoco l was approved by the University President's C ommittee ..
Anima l Care Committee.
For groups I, II and III mice were pu rchased at 3 weeks o f age wh ile lor
gro ups IV, V and VI they were purchased at age 6-7 weeks. In the Anima l Care
Facility they were acclimatized for 1 or 2 weeks during which they had free access
to ordinary drinking water and food, then each was assigned randomly to one of the
expe rimental groups. Chow food pelle ts that were used by some g roups (Rodent
Cho w No. 5012,Ralston Purina, St. Louis, Missouri) were analyzedfor trace e lement
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conten ts and found to contain on average 0.09 mg cadmium /g and 43 .3 mg zinc/g.
Other constituents are shown inTab le 4-1, and constituents of the zinc deficient lood
pe llets are shown in Table 4-2. During the treatment period m ice had free access to
drinking water . On a weekly basis throughout the whol e exper iment general health,
we ight and food cons umption were monitored and recorded.
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TABLE 4-1
CONST ITUENTS OF THE REGULAR CHOW DIET
Crude protein
Crude tat
Crude fiber
Ash
not less than
not less than
not less than
not less than
22.2%
4.0%
5.0%
3.0%
Groun d extruded yellow corn , soybean meal, fish meal,
can e molasses, wheat midd ings, dehydrated alralra meal,
grou nd oats , brewers dried yeast, wheat germ meal, dried
beet pulp, soybean oil, dic alcium phosphate, calcium
carbonate, salt, vitamin 8-12 supplement, calcium
pantothenate, chol ine chloride, riboflavin supplem ent,
thiamin, niacin supplement, Dl meth ionine, vitamin A
supp lement, 0 activa ted anim al sterol (source of vitamin 0-
3), vitamin E supplement,ca lcium iodate, manganous oxide,
ferrou s carbonate, cobalt carbonate, coppe r sulfate, zinc
sul fate.
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TABLE4-2
CONSTITUENTSOFZIN C DEFICIENT DIET
Egg White
Corn Oil
Corn Starch
Sucrose
AtphaceJ Hydrolyze
Choline Bitartrate
A1N-76C Vitamin Mlxture
A1N-76 Mineral Mixture
Biotin
18.00%
10.00%
44.30%
20 .00%
3.00%
0 .20%
1.00%
3.50%
20 mg/ kg
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4.2 Sacrificing the mice and collecting their tissues:
Animals were sacrificed in the animal care procedure rooms. Each mouse was
anesthetized with ether and killed by cervical dislocation , the abdominal skin was
wetted with 70% ethanol and the cavity was opened , aseptic precautions were
maintained to avoid contamination of the sp leen that was used for culture work .
Sterilized scissors were used to cut through the peritoneal membrane, spleen was
removed and transferred to a tube containing sterile culture medium, subseq uent
handling of this organ was done in a level A laminar flow hood (Envirco,
Biodynamics Inc., Albuquerque, New Mexico), this followed by removal of the kidney
and thymus . Organs were transferred to preweighed containers which were weighed
again to obta in t'te organs weights. A single electronic balance (Mettler PC 180,
Grelnfensee. Zurich, Switzerland) was used throughout 're exceriment.
In animals whose kidney or thymus sections were prepared for electr on
microscop ic examination, the required organ was removed first to maintain the
ultrastructural integrity of the organ.
4.3 Lymphocyte counts in the blood thymus and spleen:
(A) Lymphocyte Count in th~:
Immediately alter killing, toe right atrium of the heart was opened and to ul of
blood was collected and transferred to 190 ul of Turk's solution (0.1 gentian vtotet,
10.0 ml 95% ethanol and 0.5 ml acetic acid in 98.5 ml distilled water). A small aliquot
of that diluted blood was transferred to a Neuber Counting Chamber, and the
lymphocy tes counted with a light microscope .
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(8) Lymphocyte count in the thymus:
A known volume of normal saline was added to a petridish, then the thymus
was gently homogenized using a tissue pestle on E-C ce\lector tissue sieve (Mandel
Scienlific, Rockwood, Ontario) with a mesh size 50 and opening size 0.28 moo, that
allowed the contents to pass through and leave the capsule behind. Large debris
were broken down by gentle agitation with a pasteu r p'pettc, a single cell
suspension was obtained bypassing the solution throug h graded needles (21G and
26G). 10u1o f the final solution was added to 190 ul ge ntian Violet, small aliquot of
it was transfe rred to a Neuber counting chambe r and lymphocyte counted with a
Ughtmicroscope. Results are expressed as total lymphocyte count in the thymus.
(C) Lymphocyte count in the soleen,:
The entire procedur e lor handling spleen cells was carried out with total aseptic
precautions in a laminar now hood.
A known volume of sterile RPMI 1640 with L-glutamine without sod ium
bicarbonate (NO. 1060120, Flow Laboratories, MCClean, Virgin ia) was placed in a
petrt dish. Spleen was gently teased with two curved needles. This maneuve r
allowed to squeeze aut the contents and leave the capsule behind. Large cellular
clumps were broken down by gentle agitatio n with pasteur pipette and deb ris
removed by secimentatlon for 10 minutes. Supernatant was collected and a single
cell suspensio n obtained by passing the solution throug h graded needles (21G and
26G). 10 ul of the final solution was diluted in 190 ul gentia n violet and lymphocyt es
were counted in a Neuber chamber.
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4.4 In vitro stimulation of spleen cells wjth mitogens :
(A) Preparation 01splenic eel!syspension:
Spleen cells was pr epared as described in section 4.3.C. Cells were washed
three times in sterile RPMI 1640 (Flaw Laborator ies, McClean, Virginia) at 200 xg for
10 minutes each. After the final wash cells were counted and resuspended to 1 x
106 Iymphocytesjml in sterile RPMI 1640 supplemented with sodium bicarbonate,
10 ul of penic illin, 100 mg/ml of streptomycin, 250 ugj ml of fungizone (Gibco
Laboratories, Chagrin Falls, Ohio) and 5% heated inactivated (570c for 30 minutes)
fetal calf serum (Bocknek Organic Material, Rexda le, Ontario). Aseptic precautions
were maIntained for all the previous and subsequent procedures.
(B) Stimulalion of spleen cells with phytQhoemaglytinin (PHA)
A nat bottom microc ulture plate was used (Flow Laboratories, McClean,
Virginia). The procedures were set up in triplicate for each mitogen and contro l
culture. For mitogen stimulation, 200 ul Qf spleen ce ll suspension (1 x 106)
Iymphocytes/ml was placed in each well + 20 ug of phylohaemaglutinin (PHA)
(WeUcQme, Diag nostics, Dartford, England), while for control culture 20 ul of norma l
saline was delivered in each well Instead 01the PHA.
The culture plate were incubated for 72 hours at 370C in a humidified
atmosphere contain ing 5% CO2 in air. In the tina t 4 hours 01incubation O.Su Ci of
[3H1thymidine with a specific activity of 2Ci/m M (New England Nuclear, Boston,
Massachuseets) was added in each well to assess DNA synthesis, cells were the n
harvested on g lass fiber filters(Mandel Scientific, Rockwood, Ontario) with a rnultlple
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automatedcellharvester(Thertek, Flow Laboratories, Rockville, Maryland). Filter
papers were left fo r 2 days to be completely dry then the discs were put in
scintillation vials and 8 mlof scintillationfluid wasadded (BDH chemicals, Toronto,
Ontario) and counted for radioactivity by liquid scintillation system, fullerton
(California). Results wereexpressed asstimulation index:
Mean countsper minute of
Stimulation index Idolicate stimylatedculture
Mean counts per minute of
triplica:J control ct nure
4.5 Direct andindirecj splenic plaque.forming cel! response:
Plaque formingcell (PFC) in responseto sheepred blood cells was assayedby
amodified(Kappler 1974) Jerneplaque assay.
{A} Immunization of themice:
For estimation of direct (lgM) or indirect(lgG) plaque formingcells,mice were
injected4 or 8 days inlraperitonealiy with0.2 mlofsheep redcejs beforesacrificing.
Sheep red cellswere stored in Alsever solution (Woodlyn Laboratories, Guelph,
Ontario), were washed three times in normal saline at 450 xg, 10 minutes each,
buffycoatwasremovedafter eachtime.After thelast washcellswereresuspended
to 20%in normal saline.
(B) Reverse hemolytic p1~:
1. Spleencelswere preparedas in section (4.3.C). Ceilswerewashed3 timesin
Hank's balanced salt solution (No. 18104, Flow Laboratories, McClean,
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Virginia). For the next wash the balanced salt salution was added and the
process repeated. After the 3rd wash supernatant was aspirated and cells were
resuspended in SSScon taining 5% heat inactivated (57° C for 30 minutes) tetar
calf serum, then cells were adjusted to 2 x 106 lymphacytes / ml.
2. Sheep red cells were prepared to be used as target far lysis in the plaque
assay. Cells were washed 3 times in normal saline, each time cells centrifuged
at 450 x 9 for 10 minutes, buffy coat was removed and normal saline was
added to bring up the volume for the next w ash. After the sro wash the
concentration o f the sheep hl O O.llls was adjusted to 16% in BSS. 40 microliter
of the 15% solution was added to 1ml SSS to make a 0.57%solution.
3. Guinea pig compleme nt (GibeD Laboratories, Grand Island, New York) and
rabbit anti-mouse IgG (Miles Scientific, Pexdete, Ontario) were absorbed over
sheep red blood cells to preventnon-specificbind ing.The sheep red cells were
washed three times at 450 xg. 10 minutes each, buffy coat was removed after
each time. 2 ml packed sheep red cells was added to 10 ml guinea-pig
complement or anti-mouse - IgG and incubated for 30 minutes al 40C with
continuous rotati on at 10 cycles/minute. After incubation packed cells were
centrifuged at 450 x g fo r 10minutes, supernatant removed and incubated with
sheep blood ce lls again. The process was repeated 3 times. After the
absorption , 500 ml volume of the guinea-pig compleme nt or anti-mouse - IgG
was aliquoted and stored at _l OoC. For the p laque assay, 1/10 dilution of
guinea-pig comp lement and 1/40 dilution for son-mouse - 196 was used.
4, For performing direct (lgM) antibody plaque assay , flat bottom microculture
plates were used (ROW Laboratories, McClean, Virginia). In each well 01 the
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crete 40, 30, 20 urspleen cell suspension (8, 6, 4 x 106 lymphocytes) along with
50 ut of 0.57% sheep red cells and 50 ut of 1/ 10 dilution of guinea-pig
complement were delivered. The final volume in each well was brought up to
190 ut by adding an appropriate amount of culture medium. Oonsmuents of
each well are shown in Table 4-3. The assay was set up in triplicates for each
sample and cell dilution. Plates were centrifuged at 55 x g for 3 minutes to
obtain a monolayer and incubaled at 37°C with 5% CO2 in air. The number of
plaques were determined with an inverted microscope . Under the microscope,
the plaque looks like a clear zone of red cell lysis with a lymphocyte ir' the
center (Fig. 4-1J. Results are expressed as plaques/10 6 spleen cells and
plaques/spleen.
5. For indirect (lgG) plaque assay, a sImilar procedure as for direct (IgM) assay
(step number 4) was followed, but an additional 50 ul of 1/ 40 rabbit entl-mouse
IgG was added to each well. To get the number of IgG producing cell count,
direct PFC number was subtracted from indirect plaque forming cells.
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TABLE 4-3
Direct and Indirect plaque Assay
Constituents Lymphocytes/Well Lymphocytes/Well
of
Culture Wells 8x106 6x1Q6 4x1Q6 8x106 6x106 4x,rfl
Dirr·ct (lgM) plaque Indirect C1gG) Plaque
Spleencell
suspension
(2x106ml) 40 ul 30 ul 20 ul 40 u! 30 ul 20 ul
Sheep red
blood cells
(0.57%) 50 ul 50 ul 50 ut 50 ut 50 ul 50 ul
Guinea-pig
complem ent
(1/ 10) 50 ul 50 ul 50 ul 50 ul 50 ul 50 ut
Mouse
anti·IgG 50 ui 50 ut 50 ul
Culture medium 50 u 60 ul 70 u! 50 ul 60 uJ 70 ul
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FIG 4-1
Antibody producing lymphocyte. The clear area of red cell lysis around a
lymphocyt e is counted as one positive plaque.
4.6 Assay for natural killer cell activitY:
Natural killing is based on the fact thai unsensitized lymphocytes from normal
individuals are spontaneously cytotoxic for a variety of target cells (Ortaldo and
Herberman, 1984).
(1) Preparation of the splenic cell suspension is similar to that descr ibed in section
4.3.C. Lymphocytes were isolated by density gradient centrifugation. The
suspension of spleen cells was layered over Ficoll-Hypaque (Sigma Chemical
CompanY,5t. Louis, Missouri) with a specific gravity of 1.09 and centrifuged at
400 xg for 30 minutes at room temperature. A visible interface which formed of
lymphocytes between the two layers was collected and washed 3 times in RPMI
• 1640 at 200 xg for 10 minutes each, then counted and adjl,.;sted to a
concentration of 20 x 106 cellsyt ml in RPMI1 640 with sodium bicarbonate , 100
ul/ml of penicillin, 100 mg/ ml of streptomycin , 250 mg/ mt of fungizone (Gibeo
Laboratories. Chagrin Falls. Ohio) and 10% heat inactivated (57% for 30
minutes) fetal calf serum (Bocknek Organic Material, Rexdale, Ontario) this
suspension was used as the effector cells in the natural killer can assay.
(2) For labelling of target cells, Molony virus induced mouse lymphoma cell line
VAC-1 (American type tissue culture, Rockville, Maryland) maintained in
continuous culture in complete culture medium was used as target cells . 200
IJ.Ci51Cr as sodium chromate (New England Nuclear Corp . Boston, Mass.) was
added to 5x106 tumour cells in 0.5 ml of culture medium and incubated for 60
minutes at 37°C with continuous rotation at 10 cycles/minutes, then cells were
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washed twice in assay medium , counted and resuspende d to the final
concentration (0.BX10S cells/ml).
(3) For sotting up the chromiu m release assay, a V-bottom microcultu re plate was
used (Flow Laboratories, McClean, Virginia). In each well 50 ut tabelled target
cell suspensio n (0.8 x 106/ml) and 100 ul effector cell suspensio n (20 x 106/ml)
was del ivered with resultant of 50 :1 effecto r target ratio.
Spontaneous 51Cr release from target cells was measured in the absence of
effector cells and total release was measured by treating the target cells with
100 ul/well of 1% Nonidet P40 (Sigma Chem ical Co mpany, St. Louis, Missouri).
In each well, volume was maintained at 200 ul by adding 50 ul of cult ure
medium . Constituents of the culture wells are shown in Table 4-4.
Culture was performed in triplicate, plate was Incubated at 37°C In 5% CO2 air
atmosphere for 4 hours. After incubation the plate was centrifuged at 400 xg for
5 minutes and 100 ul of supernatant was col lected from each well. Radioactivity
in the supernatants was co unted in a gamma coun ter (Beckman Instruments,
Fullerton, California). The percentage of isotope released from the target cells
was calcu lated by the fo llowing formula:
_ _ _ _ _ _ ___ _ _ _ _ _ _ _ _ x100Percentrelease :::
Mean count per
minute of
experimental release
Mean count per
minute of total
release
Mean count per
minute of
spontaneous release
Mean cou nt per
minute of
spontaneo us release
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TABLE 4-4
Assay at Natural Killer Cell Activity
50:1
Target/Effector Total Spontaneous
Ratio Release Release
ul{well ul{ well ul{ well
Effector cell
(;>(JX1Q6/ ul) 100
Target cell
(O.8x1Q6/u1) 50 50 50
Culture medium 50 50 150
1,0% nonidet P40 100
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4.7 Enum eration of I .lymphocytes and subsets in the spleen:
(1) Spleen cell suspension was prepared as explained before in section (4.3.C).
Washed 3 times at 200 x g for 10 minutes each, after the last wash the supernata nt
was removed and the total volume of the packed cells was between 4-5 mi.
(2) Lysis of the red blood cells was obtained by hypoton ic ShOCk (B.B. Mishell and
S.M. Shiigi, 1979), while slowly vortexing the packed cells, 1 ml of distilled water
was added slowly drop by drop followed by 1 ml of double concentration (2 x
RPMI) slowly, then suspension was centrifuged at 200 x g for 10 minutes and
cells adjusted to 2 x 106/m l in RPMI 1640.
(3) T-Iymphocytes and subsets in the spleen were enumerated by direct
immuno fluorescence staining (Becton Pickinson Procedures). This method uses
a fluorescein conjugated antibody directed to a speonc antigen for the
demonstra tion of cellular localization of that specific antigen. Antibodies are
fluorescein conjugate anti-mouse Thy 1-2 for T cells, phycoerythrin conjugate ann-
mouse ~T4 for helper/i nducer and fluoresce in conjugate anti-mou se Lyt-2 for
suppres sor / cytotoxic cells (anfrom Becton Dickinson immunocytometry systems,
Mountain View, California).
(4) 50 micro liter of the stock was added to 20 ul of nuorescen conjugate anti-mou se
Thy 1·2, phycoerythrin conjugate anti-mouse ~T4 or fluorescein conjugate anti-
mouse Lyt -2 for T cell, helperl inducer and suppresso r/cy totoxic cells respect ively.
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(5) The mixture was incubated for 30 minutes at 4°C , washed 3 times with Dulbecco-
phosphate-buffer saline (PBS) (NO. 450-1300, Gibco laboratories, Grand Island,
New york)containing 0.1% sodium azide at 300 xg for 5 minutes each at 4°C.
(6) After the last wash cells were resuspended in 0.5 ml cold medium and 1 ml
paratorrnaldehyde 2% (Gibco Laboratories) was added to fix the cells prior to
analysis. Analysisof the different cells was carried out by EPICS CO flow cytometry
system (Coulter Corporation, Hiapeah, FL, USA).
4.8 Electron microscopy of the kidney and the thymus:
Electron microscopic procedure was performed in the electron microscopy
department, Faculty of Medicine, Memorial Universityof Newfoundland. Kidney and
thymus sections were examined at 0, 3 and 6 weeks of observations. Six animals
from each group were examined.
Kidney and thymus were collected immediately after sacrificing the animal. All
steps for tissue examination were carried out in a fume hood at room temperature
while tissues were placed on a rotator.
nssue was diced into small pieces (1 cubic mm) and immersed for 20 minutes in
a mixture of paraformaldyde and glutaraldehyde in a.2M sodium cacodylate buffer
(PH 7.4) for fixation, then the tissue was washed thoroughly with a.1M sodium
cacodylate buffer and post fixed for 10 minutes with 1% osmium tetroxide in 0.2M
sodium cacodylate buffer, washed with a.1M sodium cacodylate buffer and
dehydrated by passing through serial concentrations (70%, 95% and 100%) of
ethanol for 3 minutes in each concent ration with two changes, then after, for 10
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minutes for absolute ethanol with two changes. After dehydration, the tissues were
immersed in absolute acetone for 10 minutes with two ch anges, transferred to a
50:50 mixture of absolute acetone and Epon 812 embedding resin for 10 minutes,
then to 100% resin for 10 minutes with two changes. Finally, the tissues were
embedded with resin in capsules and polymerized at 70DC for 16 hours in a
Rechert KT-100 oven.
Sections 0-5 um were cut with a LKB Huxley ultramicrotome and ultra-thin silver
sections were prepared with a Reichert OMU3 ultratome. Sections were stained
with lead citrate and uranyl acetate and observed under a Phillips 300 transmission
electron microscope .
For observation under light microscope, sections with the same thickness were
stained with 1% toluidine blue in 1% sodium borate.
4.9 Trace Element Analysis:
Portions of the kidney were weighed, freeze dried for 24 hour s and stored at 40C
for cadmium and zinc analyses. The analyses were done in the laboratory of Or.
Bo Lonnerdal, Department of Nutrition , University of California, Davis. The tissues
were ashed at 500°C for 16 hours in porcelai n cruc ibles. The ash was dissolve d
lor 30 minutes in 0.5 ml pure HN0 3 and 4.5 ml 1 N Hcl and the resulting solution
was made up to 10 m! with deionized distilled water. Acid washed contai ners were
used in all stages of the procedure . The samples were analysed by atomic
absorpt ion spectroscopy (Perkin Elmer, Norwalk. Connec ticut) (Beaty, 1978).
Contro l mice tissues were analyzed with a HGA-300 graphite atomizer with
deuterium arc background correction, while remaining samples were analysed by
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flame with a single slot a-lnch burner head. All results are reported as ug/g wet
weight of tissue.
4.10Statistical analysis:
Data were stored on EDT file in the VAXNMS main frame computer system of
the Memorial University of Newfoundland (EDT Editor Manual, 1980)and analyzed by
the statistical packages MINITAB (Ryan, Joiner and Ryan 1985 a; Ryan, Joiner and
Ryan 1985 b) and SAS(Cody and Smith 1985). Data were stored in a two-dimensional
matrix suitable for handling by the statistical packages. A one way analysis of variance
was performed to compare the groups. When a difference was found to be present at
P<0.05, treatment effectwas inferred and Duncans' rnuttlpte-ranqe test was performed
to make multiple comparison between the means. Significancelevels used were 0.05
or less. When analysis of variance did not reveal any significant difference no further
analysis was done.
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CHAPTER V
Results
5.1 Generalhealth of mjce:
The micewere examinedonce a weekthroughout the durationof the experiment
for signs01cadmium toxicity, zinc deficiency, failureto gain weight,altered food intake
and death. No toxic manifestations wereseenin the cadmiumtreated animals.Mice given
a low zincdiet showed loss of hair from alfover the body especiallythe tail (Fig5·1) at
the second observation period (week3). None of the animals died during any of the
treatmentschedules. Ondissection, thethymus1n 3 of themicetreated withzincdeficient
diet wasenlargedand hypertrophied. Otherorgans did not haveanygross pathological
Changes. Weights orthe animalstakenweekly on the sameday of the week and at the
samehour for thefour time periodsareshown in Table 5.1. Allthe animals underdifferent
treatment schedules had a tendencyto loseweight, moreso for those treated with the
zinc deficient diet. However, there were no statistically significant differencesbetween
various groups for weight loss. It was also seen that atter cessationof treatment weight
gain wassimilarin all groups.
Food consumptionwas measured weekly at the same time. Animals housed in
wre-mesbedhanging cageslostconsiderable amountsof foodbecause as the size of the
pelletsbecamesmal they tendedto drop from the cage. Food waste wasmeasured and
subtractedfrom theweekly fooddisappearanceto calculate net food consumption. Table
5.2 reflects lood consumption during the3 observation periods. Theresultsdid not differ
among the six treatment groups during the differentobservation periods.
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A
Figure 5.1
Fig. (A) shows control mouse (right) and low zinc-treated mouse (left) with loss of hair
from all over the body especially the tail.
Rg . (8) shows more details of the tail sections from the control mouse (left) and low
zinc-treated mouse (right) with loss of hair and bleeding spots .
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TABLE 5-1
WEIGHT OF THE MICE (gm)
Group Treatment
Before
Treatment a Week 3 Week 6 Week
No
treatment 15.8 ± 1.69 22.17 ± 1.52 25.08 ± 1.31 27.42 ± 1.30
zn" for 4 wks
zn' + Cd for 3
wk. 15.0 ± l.4B 21.50 ± 3.82 22.92 ± 4.74 26.25± 1.40
None for 3 wks
In" for 4 wks
zn" + Cd lo r 3
wk. 15.0 ± 1.47 21.50 ± 3.82 22.92 ± 4.74 27.58± 2.15
Zn+ for 3 wks
None for 4 wks
zn" + Cd for 3
wk. 16.2 ± 1.89 20.66 ± 1.07 24.08 ± 0.99 26.83± 1.50
None for 3 wks
None for 4 wks
Cd for 3 wks 16.8 ± 1.77 20.75 ± 1.80 24.58 ± 1.50 27.91 ± 0.99
None for 3 wks
None for 4 wks
zn" +Cd lor 3
wks 16.5 ± 1.78 19.75 ± 1.76 22.50 ± 1.88 26.58 ± 1.83
None for 3 wks
There were B animals in each group ,
Results are expressed as weight (gm) given as mean ±SD.
There are no statist ically significant differences (p ::> C.OS)between the treatment groups
by one-way analysis of variance,
zn ' : Zinc 1 ppm , Zn + : Zinc 50 ppm, Cd : Cadmium 50 ppm
- 56-
TABLE 5-2
FOOD CONSUMPTlON (gm{day)
Group Treatment o Week 3 Week 6 Week
No treatment 3.32 ± 0.43 3.40 :! 0.49 4.14:! 0.58
zn " for 4 wks
Zrl" + Cd for3
wl<s 3.21 :t 0.62 3.18 ± 0.37 3.81 .t 0.63
None for 3 wks
Zn" for 4 wks
Zn" +Cd ror a 3.27 ± 0.56 3.24 ± 0.38 4.04 ± 0.61
z~~sfor 3 wks
None for 4 wks
zn + + Cd for 3 3.29 ± 0.35 3.28 ±0.34 4.45 ±0.71
wl<s
None for 3 wks
None for 4 wks
Cd for 3 wks 3.22 :! 0.38 3.25 ± 0.46 4.18 t 0.61
None tor 3 wks
None for 3 wks
Zn- + Cd for 3 3.12 ± 0.39 3.20 ± 0.52 4.33 ± .0.59
wks
None for 3 wks
Results are expressed as mean ± SD.
There are no statistically significant differences (p > 0.05) between the
treatment groups by one way analysis of variance.
Zn-: Zinc 1 ppm, Zn" : Zinc 50 ppm, Cd: Cadmium 50 ppm
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5.2 Organs weights :
After sacrificing the animals, the spleen, thymus and kidney were removed and
weighed immediately. Tables 5.3, 5.4 and 5.5 reflect the weight of different organs at the
3 observation periods (0,3 and 6 weeks). None of the organs showed significant weight
loss and there was increasing weight gain with age a! all observation periods. However,
animals treated with zinc deficient diets had tess weight gain in the different organs, even
after cessation of treatment in comparison with the control group . However, this difference
did not reach the level of statistical significance.
5.3 Lymphocyte counts in the blaod spleen and thymus:
l ymphocytes were coun ted in 10ul of blood collected from the right atrium of the
heart and from all suspensions prepared from homogenized spleen and thymus. Results
are shown in Tables 5.6, 5.7 and 5.8.
Animals treated with zinc deficient diet had slightly decreased numbers of
lymphocytes in the blood after 4 weeks of treatment (week a observation). However,
con current administration of cadmium caused a significant decrease in the lymphocyte
counts in comparison with the control group. Even animals treated with cadmium only
had a significant decrease in the lymphocyte counts. lymphocyte count of the spleen
cells and thymus did not differ among the treatment groups at any point. However,
animals treated with zinc deficient diet had a tendency to decrease lymphocy te counts in
comparison with othe r treatment groups, but this did not reach levels 01 statistical
significance.
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TABLE5-3
WEIGHT OF SPLEEN (gm)
Group Treatment o Week 3 Week 6 Week
No treatment 0.0871: 0.022 0.1111:0.015 0.1271:0.018
zn" for 4 wks
zn' +Cd for 3
wks 0.098 1:0.026 0.105 ± 0.038 0.123±0.023
None for 3 wks
I n" for 4 wks
In" +Cd for 3
Z;~sfor 3 wks 0.113:!:0.106
None for 4 wks
zn" - coro- a 0.116 ± 0.202 0.119 t 0.017
wks
None for 3 wks
None for 4 wks
Cd for 3 wks 0.112 ± 0.010 0.128±O.O16
None for 3 wks
None for 3 wks
I n" + Cd for 3 0.097 ± 0.234 O.109±0.006
wk s
None for 3 wks
8 animals in each group. Values are expressed as mean ± SO
There are no statistically significant difterences (p :> 0.05) between the
treatment groups by one-way analysis of variances.
zn' : linc 1 ppm, In " : l ine 50 ppm, Cd'Caomom 50 ppm
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TABLE 5-4
WEIGHT OF THYMUS (gm)
Group Treatment o Week 3 Week 6 Week
No treatment 0.069 ± 0.030 0.083 ± 0.029 0.090±0.020
Zn" for 4 wks
Zn- +Cd for 3
wk. 0.0 53 t 0.018 0.077 ± 0.016 0.072 ±0.021
None for 3 wks
zn" for 4 wks
Zn" +Cd for 3
wk. 0.093z0.031
Zn+ for3 wks
None for 4 wks
Zn+ +C d lor 3
wk. 0.073 ± 0.028 0.091 ± 0.017
None lor 3 wks
None for 4 wks
Cd ior a wks 0.090 ± 0.016 0.110 ± 0.531
None lor 3 wks
None for 3 wks
Zn" +Cd for 3
wk. 0.070 ± 0.023 0.87 ± 0.020
None for 3 wks
Values are expressed as mean ± SD
There are no statistica lly significant differences (p > 0.05) betwee n the different
group s by one-way analysis of variance.
Zn-: Zinc 1 ppm, zn + : Zinc 50 ppm, Cd : Cadmium 50 ppm
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TABL E 5,5
WEIGHT OF KIDNEY (gm)
Grou p Treatment a Week 3 Week 6 Week
No treatment 0.282 ± 0.195 0.356 ± 0.052 Q.39J±o.C8J
Zn' for 4 wks
zn ' +Cd for 3
wk. 0.274 ± 0.046 0.338 ± 0.099 Q349± o.cro
None for 3 wks
z o' for 4 wks
zn " - c o for 3
wk. 0317± o.1rn
Zn + for 3 wks
~~~e1~d4f~rk~
wk. 0.359 ± 0.057 o.42)± 0.00
None for 3 wke
None for 4 wks
Cd for 3 wks 0.357 ± 0.023 OE ± 0005
None for 3 wks
Non e lor 3 wks
Zn" +Cd for 3
wk. 0.271 ± 0.024 0.3:19 ± 0.005
None for 3 wks
Values are expressed as mean ±SD
Th ere are no statistically significa nt difference (p < 0.05) between the treatment
groups by one-way analys is of variance .
Zn": Zinc 1 pp m, Zn + : Zinc 50 ppm , Cd :Cadmium 50 ppm
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TABLE 5-6
LYMPHOCYTES COUNT IN BLOOD X 106/ML
Gro up Treatment oWeek 3 Week 6 Week
No treatment 4.160 ± 0.651 3.922 ± 0.424 4.343± 0.782
In" for 4 wks
In- +Cd for 3
wks 3.932 ± 1.009 3.202 :t 0.357" 3.735± 1..a:G
None for 3 wks
In - for 4 wks
In " +Cd for 3
wke 4.$3 ± Q7S3
In+ for 3 wks
None for 4 wks
In + - ce iea
wks 4.157 :t 0.509 42i'O ± 1.843
None for 3 wks
None for 4 wks
Cd for 3 wks 3.658 ± 0.567" 3.853±Q9i'O
None for 3 wks
None for 3 wks
I n" + Cd for 3
wks 3.837 ±0.296 42J2 ±Q633
None for 3 wks
Values are expressed as mean ±SD
" Sig nificantry different at p c 0.05 from other values in the same Col umn by
~~~~.~~~s1mpu~~,lez~a.r~~i~~s;0 ppm, Cd : cadmium 50 ppm
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TABLE 5-7
LYMPHOCYTE COUNTS IN SPLEEN x 106
Gro up Treatment a Wee k 3 Week 6 Week
No treatment 181.01 ± 37.66 234.67 ± 12.59 276.72±00.94
zn" for 4 wks
Zn- + Cd for 3
wk. 166.78 ± 17.73 181.25 ± 73.11 2)4.37 ±00.73
None for 3 wks
zn' for 4 wks
zn" +Cd for 3
wk. 210.15±00.00
zn" for3wks
None for 4 wks
zn" + Cd for3
wk. 230.76 ± 58.55 278.43 ±41.44
None for 3 wks
Non e for 4 wks
Cd for 3 wks 231.56 ± 29.72 254.00 ± 24.84
None for 3 wks
None for 3 wks
zn' + Cd for 3
wk. 188.42 ± 39.64 197.BS±4 1ffi
None for 3 wks
Val ues are expressed as mean ±SD
There are no statistically s ignifican t di fference s (p < 0.05) between th e treatment
~~~~~i~~~ ~~%~~~ ~~~~~\~f ;;~~n~~~ cad mium 50 ppm
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TABLE 5-8
LYMPHOCYTE COUNT IN mE THYMUS x 106
Group Treatment oWeek 3 Week 6 W eek
No trea tment 85.80 :!: 18.83 148.35 ± 66.80 114.15::tiU71
Zn' for 4 wks
Zn- +Cd for 3
w1<, 71.9 0 :!:14.5 7 128.68 ± 27.36 127.50 :!: 53.23
None lo r 3 wks
Zn' fo r 4 wks
zn ' +Cdfor3
wk' 151.62:1:33.65
Zn+ fo r 3 wks
None fo r 4 wks
z-" +Cd for 3
w1<, 146.81 :t 27.92 152.ro :l:63.El3
None fo r 3 wks
None fo r 4 wks
Cd for 3 wks 119.09 :t 41.08 1:B.43:!: 42.47
None for 3 wks
None ror 3 wks
lll' +Cd for 3
wk, 88.09 ± 42.14 172.83 :!:6427
NOlle fo r 3 wks
Values are expressed as mean :!:SD
There are no statistically significant difference (p c 0.05) betw een the tr eatmen t
gr~ps by one-way ~nal.ysi s of variance.
Zn : zinc 1 pp m , In : znc 50 ppm, C d: cadm ium 50 ppm
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5.4 Stimulation of lymphocytes with p~:
Spleen cell cultures were stimulated with T cell mitogen phytohemagglut inin (PHA)
for 72 hours and during the last 4 t.ocrs radioactive thymid in~ incorporation was
measured. Tab le 5.9 presents the stim ulation index (ratio 01 thymidin e uptake between
stimulated (I.e. PHA containing) and non-stim ulated cells). Animals treated w ith a zinc
deficient diet for 4 weeks (week a observation) had a significant decrease in the mea n
stimulation index in comparison with the co ntrol group . Concurrent admin istration 01
cadmium tende d to increase the mean stimu lation index with a grea ter increase after
cessation of treat ment. However, the difference was not statistically significant. Animals
treated with zinc deficient diet and cadmium for 3 weeks (Group 6) had a significant
decrease in the mean stimulation index that continued evenafter cessationof treatment.
Animals which had received cadmium and zinc toget her had values sim ilar to the
nontreated cont rols, whi le those receiving cad mium alone had values that tend ed to be
higher. This d ifference, however, did no t reach levels of statistical significance.
5.5 Assay of natur31-killercell activity:
Natural-killer cen activity wasmeasured by assay of 4 hour chro mium re lease from
target cells {Mol oney v irus induced lymphoma call tine YAC·1 labelled with 5 1Cr}. Tab le
5-10 presents the results at the different observation periods. Animals treated with zinc
deficient diet had a significant decrease in natural-kuler cell activity. Three weeks after
concurrent cadmium adm inistration (week 3observatio n) rrc re significant depression was
observed. After cessation of treatment there was te ndency of increased ac tivity an d
greater increase with concurrenl zinc administrat ion. This difference still was st atisticall y
significant incomp arison with the nontreatedcontrols. Groups treated withcadm iumalone
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TABLE 5-9
STIMULATION OF THE LYMPHOCYTE S WITH PHA MITOGEN S
Group Treatment o Week 3 Week 6 Week
No treatment 6.35 ± 2.22 6.40 ± 2.07 6.54 ± 1.34
z n' for 4 wks
Zn- +Cd for 3
wk. *4.32 ± 1.34 5.85 ± 1.90 6.33 ± 2.15
None for 3 wks
zn" for 4 wks
Zn" +Cd for 3
wk. 5.26 ± 2.35
Zn+ for 3 wks
None for 4 wks
Zn+ +Cdfor3
wk. 6.21 ± 1.80 6.51 ± 1.14
None for 3 wks
None for 4 wks
Cd lor 3 wks 7.89 ± 3.38 7.11 ± 1.87
None for 3 wks
None for 3 wks
zo" + Cd for 3
wk. "'2.07 ± 0.32 *4.24 ± 0.72
None for 3 wks
Values are expressed as mean ±SD
*Significant difference at a week for group 2, 3 and at 6 week for group 6 from
~~~~~~a~u1e~~~;~nsf~~n~o~0m;p~ g~~~~~~~~lf6e;;~ge test.
TABLE5-10
NATURAL-KILLERCELL ACTIVITY
Group Treatment
No treatment
oWeek
24.00 i 5.94
3 Week
21 .28 ± 6.32
6 Week
23.14 :!:8.80
Zn" for 4 wks
Zn" +Cdfor3
wks ·12.71 ± 3.03 *2 .71 ± 1.38 ·1 2.29 ±5.82
None for 3 wks
Zn" for 4 wks
zn" +Cd for 3
wks ·13.38 :!:3.81
Zn+ for 3 wks
None for 4 wks
Zn+ +Cdfor3
wks 18.00 ± 5.31 23.29 ±6.80
None for 3 wks
None for 4 wks
Cd for 3wks *8.38 ± 4.90 · 12.75 ±6.62
None for 3 wks
None for 3 wks
Zn" + Cd for 3
wks ·1.0 -aco i 5.70
None for 3 wks
"Statistical significant difference at p <O.05form other values in the same column
by Duncan's mUltiple range test.
zo' : zinc 1 pp m, Zn" : zinc 50 ppm, Cd: cadmium 50 ppm
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had significant dec reased act:vity tha t continued after cessation of treatment. However,
animals treated with zinc and cadmium had valuessim ilar the control ones. Thus zinc m ay
have prevented the cadmium induced reduction In n afurar-kue r cell activity.
5.6 Direct plaque -forming cel!response;
Direct ptaque-forminq cell responses wereass ayed by injecting sheep red ce lls 4
days before killing . Then the number of splenic ly mphocyte s producing IgM antibody
against sheep red ce ll antigens were counted . Results were expressed as plaques/ 106
sp leen cells and p laq ues/spleen and are shown in T ables 5·1 1 and Fig, 5·2 respectively.
Mice treated with a low zinc diet for 4 weeks (week 0 observation) had a significant
decrease in the numbe r of pfc/ 106 spleen cells.Concurrent admin istration of cadmi um
tended to antagonise the depressing effect 01zinc d eficiency that was still maintaine d 3
weeks attar cessatio n of treatment (both with no sta tistical s ignificance). However, other
an imals treated with zinc and cad mium together h ad similar values compa red to the
non treated controls. Mice treated with cadmium o n ly had a significanl increase in the
number of piC, tha t was even maintained after cess ation o f treatment for 3 weeks. T he
number 01 IgM plaque- for ming cells/sp leen follow ed the same pattern with significant
dec rease after trea tment with zinc deficleet d ie t, however , concurrent cadmi um
administration tend ed to increase the number ofpfC but it was still significantly lower t han
the non-treated controls, that was also maintained for 3 weeks atter cessation of
treatment. Animals t reated with cadmium only had s ignilicant increase 01piC. Even a fter
cessation of treatm ent it was significantly higher tha n the co ntrol gro up (Fig. 5-2).
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TABLE 5-11
DIRECT PLAQUE FORMING CELL RESPONSE [lgM PLAQUE/ 106 SPLEEN CELLS)
Group Treatm ent a Week 3 Week 6 Week
No treatment 169.87 t 5.60 173.33 ± 7.16 178.46 ± 5.69
2 Zn"lor 4 wks
Zn" + C d for 3
wk' 131.32 ± 6.27* 174 .33 ± 7.81 169.92 ± 16.67
None for 3 wks
Zn' for 4 wks
ZO- + C d for 3
z~~Sfor 3 wks
None for 4 wks
Zn+ +Cdfor 3
wks
None for 3 wks
None fo r 4 wks
Cd for 3 wks
None fo r 3 wks
None for 3 wks
Zn" + C dfor3
wks
None for 3 wks
172.42 ± 4.67
179.14 ± 38.38 164.08 f 16.98
285.21 ± 41.08* 204.73 ± 10.00*
178.15 ± 15.44 188.03 f 29.16
"Statistical sig nificant difference at p < 0.05 from othe r values in the same
column by Duncan's multlpta-rarq e test.
zn": Zinc 1 ppm, Zn+ ; Zinc 50 ppm, Cd: Cadm ium 50 ppm
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Direct Plaque Forming CellsResponse(1gM)
80
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~~
0
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. 0 -0
·..~j:
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ill 6 week s
Gro u ps
Fig. 5.3
5 6
Directplaque forming (lgM) cellsresponse: Group I (Control) no treatment.
Group 2: Zn (Ippm) 4 weeks - Zn (lppm)+ Cd(SOppm)j 3 weeks- none3 weeks.
Group 3: Zn (Ippm) 4 weeks . Zn (Ippm) + Cd(5Oppm); 3 weeks - Zn(5Oppm) 3
weeks.
Group 4: None. 4 weeks - Zn (5Oppm) +Cd (5Oppm); 3 weeks - none3 weeks.
Group 5: None, 4 weeks - Cd (5Oppm); 3weeks- none 3weeks.
Group6: None. 4 weeks - Zn (Ippm) +Cd(5Oppm) ; 3 weeks - none 3 weeks.
• Statistical significant difference at p < O,OS from thecontrolgroupat the same
point of observation by Duncan's multiple-range tesl.
-7 0-
5.7 Indirect plague-forming cell response:
Indirect plaque-tormlnq cell response were assayed by injecting sheep red cells B
days prior to killing. T hen the number of splenic lymphocytes producing IgG antibody
against the sheep red cell ant igen were counted. Results are expressed as plaqUes/1OB
spleen cells and plaques /spleen in Table 5-12 and Fig. 5-3 respectively. Results followed
the same pattern as fo r the Ig M plaque-assay. At week 0 of observa tion, mice treated with
a zinc deficient diet had significantly lower numbers of IgG plaque forming cells in
comparison with the un treated controls. However, after 3 weeks of concurrent cadmium
administration (week 3 observation), the number of IgG PFC were similar to that of the
control group . Simila r values were observed in mice treated with zinc and cadmium
together and lower va lues in those treated with a zinc defic ient diet and cadmium for 3
weeks (group 6). Thus cadm ium antagonized the reducing effect of a zinc deficient diet
in gr oup 2 and zinc pre vented the caomlcm-lnduceo increase of IgG PFC response in
group 4. However, mice treated with cadmium only had significantly higher IgG. pfC
numbers than all the other treatment groups and even 3 weeks after cassation of
treatment those animals still tended to have higher 19G PFC number than the other five
groups. This difference was, however, not statistically significan!.
5.B Total T·lympho cyte in the spleen:
'l-lymphocy tes were counted by direct immunofluorescence staining using
conjugated monoclo nal antis era. Results are shown in Table 5-13. There were no
significantd ifferences among the groups on different treatment schedules. However, mice
treated with a zinc defi cient d iet for 4 weeks (week a ob servation) tended to have lower
total T-cell counts , and with further decrease in values observe d after concurrent cadmium
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TABLE5-12
INDIRECT PLAQUE-FORMING CEU RESPONSE IlgG PlAOUES/l0B SPLEEN CELlS]
Group Treatment oWeek 3 Week 6 Week
No treaimera 1291.0 ± 28.8 1276.2 ± 51.4 1281.6±293.2
zn- for 4 wks
zn" +Cd lor 3
wks 786.0 ± 23.3* 1290.0 ± 49.9 126O.8 ! 57
None for 3 wks
zn' for 4 wks
zn" + Cd lor3
wk s
zn" lor 3 wks
None lor 4 wks
zn+ +Cd for 3
wks
None for 3 wks
None for 4 wks
Cd for 3 wks
None for 3 wks
None for 3 wks
Zn- +Cd for 3
wks
None for 3 wks
1266 ± 56.2
1271.3! 51.8 1277.5 ± 53.4
1865.3 i 57.1* 1288.5 ± 58.2
1258.3 ± 61.3 1262.8 ± 58.6
Values expressed as mean iSD
-Statistlc al sign ificant difference at p < 0.05 from other groups on the same
column by Duncan's multiple-range test.
Zn": Zinc 1 ppm , 2n+: Zinc 50 ppm, Cd : Cadmium 50 ppm
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Indirect Plaque Forming Cells Response (lgO)
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Groups
:=ig.S .3
Indirect plaque forming (lgG) cells response: Group I (Control) no treatment.
Group 2: Zn (Ippm) 4 weeks. zn ((ppm) + Cd (5Oppm); 3 weeks - none 3 weeks.
Group 3: Zn (lppm) 4 weeks - Zn (Ippm) + Cd (5Oppm); 3 weeks - Zn (50pplll) 3
weeks.
Group 4: None, 4 weeks- Zn (SOppm) + Cd (SOppm); 3 weeks- none3 weeks.
Group5: None. 4 weeks- Cd (5Oppm); 3 weeks - none 3 weeks.
Group 6: None, 4 weeks - Zn (Ippm) + Cd (5Oppm); 3 weeks - none 3 weeks.
• Statistical significant difference at p < 0.05 from thecontrol group at the sante
pointof observalion by Duncan's multiple-range test.
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treatment for 3 weeks. However, 3 weeks after cessation of treatment, total values were
similar to that of the nentreated contro ls, however, none of the readings reached a
significant level. Mice treated with cadmium and zinc together had similar total T-cell
counts, while these treated with cadmium only tended to havelower values in comparison
with the nontreated controls.
5.9 Assay of T-lymphocvte subsets in spleen:
'r -lymphocyte subsets were counted by direct immunofluorescence staining
procedures, using monoclonal ant\-~T4 and anti LyT-2 antibodies that identify the murine
lymphocyte diHerentiation antigens CD4 + for helper/i nducer and COB+ for
suppressor/cytotoxic T cells. Results are shown in Tables 5-14 and 5-15. Table 5-16
shows the ratio of CD4+ and CDB-I· cells. The percentage of helper (CD4) cells was
significantly lower in animals treated with zinc deficient diet at week 0 obs ervation . Three
weeks after concurrent treatment with cadmium, helper cells showed even lower values.
However. mice treated with a zinc deficient diet and cadmium and thos e treated with
cadmium only had significant lower percentages of CD4+ cells in comparison with the
nontreated controls. However, animals treated with cadmium and zinc together had similar
percentages as the control groups. Thus zinc prevented the cadmium lncuced reduction
of CD4+ cell number. The number of suppressor T cells (CDB+) followed the same
pattern as for helper cells. HoweverI 3 weeks after cessation of all treatments, animals
treated with a zinc deficient diet and cadmium (group 2) had a sig, lificanUy different values
in comparison with the contro l group. Even concurrent administration of zinc tended to
increase the percentage of COB+ cells and the difference was st ill statistically sign ificant.
The ratio for CD4+ and CDB+ cells, which reflects the balance of immunoregulalory T-
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TA BLE 5-13
T·L YMPH OCYTE IN THE SPLEEN
Group Treatment oWeek 3 Week 6 Week
No treatment 61.143 ± 6.362 59.167 ± 4.956 59.429±9.572
zn' for 4 wks
Zn" +Cd tor 3
wka 56.857 ± 4.947 54.286 ± 2.632 57.429±9.981
None for 3 wks
Zn' for 4 wks
zn" +Cd for 3
wks 56.143±4.670
Zn+ for 3 wks
None for 4 wks
Zn+ +Cd for 3
wks 58.714 ± 4.231 61.714±8.480
None for 3 wks
None for 4 wks
Cd for 3 wks 53.713 ± 8.361 55.857±4.018
None for 3 wks
None for 3 wks
Zn+ +Cdlor3
wk,
None for 3 wks
53.857 ± 4.741 57.143±3 .024
7 • 8 animals in each group.
No significant differences among the groups on different treatment.
Schedules by one-way analysts of variance (P > 0.05).
z n': Zinc 1 ppm, zn": Zinc 50 ppm, Cd: Cadmium 50 ppm
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TABLE 5-14
T-CEll SUBSETS {HELPER CD4+} %
Group Treatment o Week 3 Week 6 Week
No treatment 35.14 ± 5.20 33.67 ± 5.78 31.66 ± 5.24
Zn: lor 4 wks
Zn + Cd for 3
wks 25.66 ± 4.10" 17.65 ± 1.63" 30.4 ± 6.17
None for 3 wks
zn" for 4 wks
zn' +Cd for 3
wks 32.21 ± 2.90
Zn+ for 3 wks
None for 4 wks
zn " + Cd for 3
wks 34.57 ± 3.82 31.30 ± 2.90
None lor 3 wks
None lor 4 wks
Cd for 3 wks 26.28 ± 3.49" 30.90 ± 3.40
None for 3 wks
None lor 3 wks
Zn- + Cd for 3
wks 20.56 ± 3.82" 29.80 ± 2.68
None for 3 wks
Values are expressed as mean ±SD
"Statistica l sign ificant difference at p < 0.05 from other values on the same
colum n by Duncan 's multiple-range test.
zn" : Zinc 1 ppm , Zn +: Zinc 50 ppm, Cd: Cadmium 50 ppm
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TABLE S.15
T-CELL SUBSETS (SUPPRESSORCD8+ )%
Group Treatment a Week 3 Week 6 Week
No treatment 27.57 ± 3.69 28.33 ± 4.32 28.20 ± 2.42
zn" for 4 wks
Zn- +C d for 3
wks 19.66 ± 1.36* 10.20 ± 1.78* 16.83 ± 3.86*
None lor 3 wks
zn" for 4 wks
zn" +Cd lo r 3
wks 17.60 ± 3.20·
Zn + lor 3 wks
~~~e:~d4'~rk;
wks 27.23 ± 3.82 26.71 ± 2.81
None for 3 wks
None for 4 wks
Cd for 3 wks 15.30 ± 1.49* 20.12 ± 6.96
None for 3 wks
None lor 3 wks
Zn- +Cd lo r 3
wks 17.14 ± 3.43* 21.83 ± 2.13
None lor 3 wks
Results are expressed as mean ±SD
*Statistical significant difference at p < 0.05 from other values on the same
column by Duncan's multlale-ranqe test.
zn' : Zinc 1 ppm, Zn " : Zinc 50 ppm , Cd: Cadmium 50 ppm
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TABLE 5-16
HELPER/SUPPRESSOR
Group Treatment a Week 3 Week 6 Week
No treatment 1.27 ± 0.19 1.18 ± 0.18 1.12 ± 0.19
Zn" for 4 wks
Zo" +Cd for 3
wks 1.30 ± 0.21 1.73 ± 0.36- 1.S0 ± 0.2S-
None for 3 wks
Zn' for 4 wks
Zn' +Cd for 3
wks 1.83 ± 0.2P
Zn + far 3 wks
None lor 4 wks
zn" +Cd tor 3
wks 1.27 ± 0.11 1.17 ± 0.15
None for 3 wks
None for 4 wks
Cd lor 3 wks 1.71 ± 0.39- 1.54 ± 0.13
None for 3 wks
None for 3 wks
In- +Cd for 3
wks 1.19 ± 0.17 1.37 ± 0.12
None for 3 wks
Results are expressed as mean±SD
" Statistlcal significant difference at p -c 0.05 from other values in the sam e
co lumn by Duncan'S multiple-ranpe test.
Zn": Zinc 1 ppm, Zn " : Zinc 50 ppm, Cd: Cadmium 50 ppm
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lymphocytes was higher in groups treated with cadmium after zinc deficient diet and other
groups treated with cadmium only, while animals treated with zinc and cadmium together
did not show that increase. Thus zinc prevented the cadmium induced imba lance of
immunoregulatory T-Iymphocytes. However, when zinc was given after treatment with zinc
deficient diet for 7 weeks (group 2) and concurrent treatment with cadm ium in the last 3
weeks, it did not preventnus increase.
5.10 Trace element levels in the kid~
Kidney samples were frozen at _20oC and later analyzed for zinc and cadmium
levels by atomic absorption spectroscopy. Results are shown in Tables 5-17 and 5·18.
Animals treated with zinc deficient diet had lower zinc concentrations in comparison with
the nontreated controls. Concurrent treatment with cadmium increased zinc
concen trations. However, the difference did not reach statistically Significant levels in bOth
observation periods. Three weeks after cessation 01 treatment, there was a significant
increase in nne conce ntration. Significantly higher values were observed after zinc
administration (group 3). Mice treated with cadmium only had similar values of zinc
concentration as the control group. However, after cessation of treatment, zinc levels
tended 10 increase. Animals treated with cadm ium and zinc had slight increases in zinc
levels at week 3 observation, however, these were not statistically significant.
Mice treated with a low zinc diet for 4 weeks had a slight increase in cadmium
levels. However, concurrent administration of cadmium for 3 weeks increased cadmium
levels significantly and even after cessation 01treatment, cadmium levels were still highly
significant in comparison with the nontreated contro ls. Concurrent administration of zinc
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TABlE 5·17
ZINC CONCENTRATION IN THE KIDNEY (ug{g)
Group Treatment
No treatment
o Week
22.15 ± 2.60
3 Week
22.29 ± 0.90
6 Week
22.53±2.04 be
Zn- for 4 wks
Zn- + Cd for 3
24,01 ± 1,60 cwks 20.90 ± 0,50 22,63 ± 0,96
None for 3 wks
zn' for 4 wks
Zn" +Cd for 3
26,05 ± 2.20 awks
zn" for 3 wks
None for 4 wks
Zn + +Cd for 3
22.53 ± 1,20 bwks 23.77 ± 2,19
None for 3 wks
None for 4 wks
Cd for a wks 22,97 ± 1,70 25.79 ± 2.40 c
None for 3 wks
None for 3 wks
Zn" ...Cd for 3
24.01 ± 2,50 cwks 22.09 ± 1,54
None for 3 wks
Values expressed as mean ±SD
At 6 week observation, values not sharing a common superscripts letter are
significantly different at p < 0,05 by Duncan's multiple-range test.
In": Zinc 1 ppm, Zn+ : Zinc 50 ppm, Od: Cadmium 50 ppm
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TABLE 5·18
CADMIUM CONCENTRATIONS IN THE KIDNEY (U9/ 9)
Group Treatment aWeek 3 Week 6 Week
No treatment 0.00 ± 0.00 a 0.00 ± 0.00 a 0.11 ± 0.29 a
zn" for 4 wks
Zn- +Cd for 3
9.42 ± 3.71 b 6.21 ± 0.6 1 bwks 0.51 ± 1.19 a
None for 3 wks
Zn" for 4 wks
zn" +Cd for 3
5.10 ± 1.34 bwks
zn" for 3 wks
None for 4 wks
zn" +Cd for 3
3.73 ± 0.78 c 3.60 ± 0.70 cwk'
None for 3 wks
None for 4 wks
8.30 ± 0.96 b 6.80 ± 2.34 bCd for 3 wks
None for 3 wks
Non e 10r 3 wks
zn"+Cd for 3
18.50 ± 3.20 d 11,19 ± 4.66 dwks
None for 3 wks
Values are expressed as means ±SD
In vertical rows values not shar ing a co mmon superscripts leiter are signi ficantly
different at p < 0.05 by Duncan 's mult iple -range test.
zn'. Zinc 1 ppm , Zn " : Zinc 50 ppm, Cd : Cadm ium 50 ppm
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(group 3) tended to decrease cadmium concentrations but the difference was still
significantly different from the contro l group.
Similar but slightly lower values were observed in animals treated with cadmium
only, as they had significant differences at 3 and 6 weeks of observations. Mice receiving
zinc and cadmium together had significantly higher cadmium levels in comparison with
the nontreated groups, but at the same time these were significantly lower than those
receiving cadmium alone. AnimCils receiving a low zinc diet and cadmium for 3 weeks had
significantly higher cadmium levels than all other treatment -groups, Includ ing those
receiving cadmium alone. This significant increase continued 3 weeks after cessation of
treatment (week 6 observation).
5.11 Electron microscopy af kidney and thymus:
ultrasmr cteral alterations in kidney and thymus sections were examined by
transmission electron microscopy . Four animals from each group were examined at 0, 3
and 6 weeks of observation. In kidney sections, whole nephron and interstitial tissues
were examined. Animals treated with 50 ppm cadmium In drinking water for 3 weeks,
showed abnormalities of the proximal tubular epithelial cells, as compared to the non-
treated animals. The mitochondria were increased in number, swollen and the cisterna
distorted (Fig. 5.4). Similar changes were also seen 3 weeks arter cessation of treatme nt.
Other areas of kidney appeare d normal. Animals fed with a low zinc diet only [Zn 1 ppm )
or cadmium and low zinc diet together did not show any abnormalities.
In the thymus sections. the cortex and medulla were examined. Animals treated
with cadmium only for 3 weeks and those treated with low zinc dlet for 4 weeks showed
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increased interepithelialconnective tissue. However. animals treated with low zinc diet only
also showed lymphoid cellular degeneration,more prominant in the cortical epithelialcells,
with lossof mitochOndria. cytoplasmic envelope and fragmentationof thecytoplasm in the
interepitheliaJspace (FIQ. 5.5). Mice treated with cadmium and low zinc det together did
not show ultrastructural changes of the thymus.
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ELECTRO N MICROSCOPY OF KIDNEY SECTIONS
Fig. 5.4
Electron microscopic appearance of proximal tubular cell from a control mouse (left)
and cadmium treated mouse (cd 50 ppm in drinking water for 3 weeks (right). The
mitochondria in the treated animal are increased in number, swollen and the cisternae
are distorted (x12,OOO).
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ELECTRON MICROSCOPY OF THYMUS SECT IONS
Fig. 5.5
Electron microscopic appearance of cortical part of the thymus from control mouse (left)
and low zinc diet-treated mouse (right). Treated mouse showed loss of the cytoplasmic
envelope (A) and fragmentation of the cytoplasm in the interepithelial space (8)
(x12,000).
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CHAPTERVI
Discussion
In the present study. the effects of a relatively low dose of oral cadmium
treatment and the effects of the interaction between cadmium ami zinc on the
immune system of mice fed a low zinc diet were studied. To prod uce a deficient
state, the concentration of zinc usee in the diet was very low (1 ppm). Since there
are no body stores 01 zinc, it was hoped that such a concent ration would
dramatically affect the lmnxme system in a short period. Animals treated with low
zinc diets exhibited loss of hair from all over the body especially the tail. This is A
recogn ized effect of zinc deficiency. There was, however, no welqht loss. Serum
zinc levels were reduced in animals treated with a low zinc diet in comparison with
the control group. However, these were pooled samples which is not appropriate
for statistical analysis. The same low zinc concentrattone were used before by
Hoald ley and Cousins in 1985, with significant depression of serum zinc levels, but
they did not report any changes in the general health of the animals. Fraker et al.
19B7 used the same concentrations with fall in body weight and serum level.
However, it is important to note that serum, plasma and urine zinc levels changed
rapidly during the first few weeks of deficiency and remain stable afterwards (Prasad
19B4 - Allen et al 1981 - Chandra 1980). In this study, animals received zinc-
defic ient diels for 4 weeks.
The dose of cadmium used was approximately comparable to possible
human exposure. Animals treated with cadmium only did not show any changes of
weight or food consumption. Similar doses were used in other studies (Chowdhury
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and Chandra 1987- Borgman et.ef.. 1986 · Blakley 1985 - Muller et.af., 1979) and
no general health effects were reported. However, a tendency for body weight
reduction was report ed by Malave and DeRuffino (1984) at cadmium doses of 50
pp m with more discernable weight loss after the third week of treatment. In the
present study cadmium treatment was discontinued after 3 weeks.
l ine treatment using a dose of 50 ppm did not affect the general health of
the mice when given alone or together with cadmium.
6.1 Effect of cadmium on the immune system:
Cadmium at oral doses of 50 ppm for 3 weeks did not alter the weight or
lymphocyte counts In the spleen and thymus. Similar findings were obtained by
Chowdhury and Chandra (198?} · Borgman et.al. (1986) and Malave and DeRuffino
(1984) who also used similar doses of oral cadmium. However, in this study , a
sJgn)f)cant decrease was observed in the blood lymphocyte counts when cadmium
was given alone and when given as a concurrent treatment with zinc-deficient diel.
Other investigators who used either a different route for cadmi um delivery or a
bigger dose, reported other findings in lymphoid organs such as thymus atrophy
and spleen enlargement (Suzuki et.at. 1961 - Yamada et.al., 1981).At identical dose
levels, the morphologic effects are more pronounced with IV or intraperitoneal
administration. Smaller amou nts would be absorbed and delivered to the immune
system following oral treatment and such small amounts ate probably not sufficient
to cause major patholog ical and structural alterations in different organ s.
The effectof cadmium on lymphocyte functions was mveetlqated by different
tests. Firstly. to characterize the proliferative response of spleen cells to a Tvcell
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mitogen (phytohemagg lutinin· PHA) in a 72 hour cullure system at which time the
mitogen produces its maximal effect on DNA synthesis. This was accomplished by
pulse labelling the cultu res with tritiated thymidine which is incorporated into newly
synthesized DNA. Secondly, enumeration of T· lymphocytes and subsets. one of the
indices of immunocompetence. was pertonued by direct immunofluorescence which
using specific monoclona l antibodies.
Thirdly. the effect of cadmium on IgM and IgG antibody prod ucing cell
responses to sheep red cells was estimated by direct (lgM) and indirect (lgG)
plaque forming cell response (Jerne et aI1974) .
Finally. natural killer cell activity was also estimated based on the fact thaI
unsensilized lymphocytes from normal lndlvlduals are spontaneously cytotoxic for
a variety of target cells (Ortaloo and Herberman 1984),
In the present study, cadmium at doses of 50 ppm lor 3 weeks Increased
IgM and IgG plaque-forming cell responses (Table (5·10, 5· 11] Fig . 15·2, 5·3]).
Three weeks after cessation of treatment. the responses tended to be higher than
in nontreated controls . These observations are in agreernent with those of
Chowdhury et.al., (1987) and Malave and DeRuffino (1984) who also used 50 pp m
cadmium in drinking water, However. Borgmanet.al .• (1986) reported that the same
dose of cadmium in drinking water caused depression of the formation 01splenic
plaque -forming cells In response to SRSe, though Muller. et.ef. (1979) could not
show any significant difference in the number ot plaque-forming cells after chronic
oral exposure of mice to 600 ppm of cadmium. The differences might be due to the
different strains of mice used, as the expression of heavy metal toxicity is known 10
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vary in different species and strains of laboratory animals (Malave 19B1), as is true
of the immune response itself. In the present study and also in the study of
Chowd hury, at al (19B7}and Malaveand Deruffino (1987) C57BLj6 mice were used,
however, Borgman, et at (1%6 ) used COl mice.
Other authors who used other non-oral routes of cadmium treatment
obtained different results, as parenteral edrnlntstraaon of cadmium (0.2 ugjday)
reduced the number of plaque forming cells (Eozelka et.al., 1978). A similar
suppression was produced when cadmium was administered by inhalation (Koller
et.al, 1975) and injection (Fujimaki 1985). The absorption 01 air borne cadmium
depends greatly on its physiochemica l form as well as the subsequent tate of
cadmium deposited in the respiratory tract. The extent of depos ition is a function of
the part icle size and solubility (Health Assessment Document for Cadmium, 1981).
However, its overall absorpt ion is more complete than from the gut.
Absorpt ion of ingested cadmium differsaccording to animal species and type
of compounds. A small proporti on of dietary cadmium is absorbed and the rest
excreted in the faeces (Bahcla et al 1972). Cadmium is taken up from the blood lnto
the liver where il is incorporated into metallothionein and rendered nontox ic. It is
then slowly released fnon the liver into the blood for transport to other organs.
Following parenteral administration,cadmium by-passes the portal circulation.
Similarly, when it is given by intramuscular or intraperitoneal injection, immediate rise
in tissue level occurs. Following inhalation, ne absorption from the lung is
proportionate ly more complete than from the gut. Thus in studies where cadmium
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was administered by routes other than oral treatment, a more toxic form was
delivered to the immune cells than in the present study.
For further investigation of the effects 01cadmium on the immune system.
proliferative response of spleen cells to T-cell mitogen phvtohernaqqtutlrm (PHA).
r -eef! lymphocyte counts and subsets were studied.
In this study , cadmium at Ihe dose of 50 ppm in drinking water tended to
increase the proliferative response of spleen cells to T·cell mitogen - PHA, but with
no sIgnificant difference from the nontreated controls. rme observation is in
agreement with the data of Chowdhury. et al (1987). However. Metave and
DeRuffino (1984) observed increased proliferative response of t -eens to PHA
mltog ens after 4 weeks of oral cadmium treatment. An even greater increase was
noted after 11 weeks. However, in the present study cadmium treatment WClS
discontinued atter 3 weeks. It is possible that different strains 01 mice have different
responses as C57Bl/6 are low responders. while others SUC ll as CBA mice are
high responders to T-cell mitogens {Malave and DeRuftino. 1984}. The number of
helper/inducer and suppressor/ cyto toxic 't -eens identified by the surface markers
CD4 + and C0 8+ respectively were significantly reduced after 50 ppm cadmium
treatment. This is in agreement with Chowdhury. et af (1987) who used the same
dose of cadmium treatment. r-n eo er crones could be divided into two types: TH1
makes interleukin·2 (l l -2) and interferon-gamma (IFNY), and TH2 secretes B-Cf!11
stimulating factor (B81-1), bo th TH1 and TH2 produce IL-3. II is possible that
changes in Iymphokine production are due to reduced TH1, a subset 01T-helper
cells that synthesize these Iymphokines. Cadmium is known to adversely affect
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enzyme function and protein synthesis in various tissues (Kostial 1986) it could
cause reduction of Il-2 and IFNy which are important for T-helper cell proliferation
and killing of intracellular organ isms. The selective reduction by cadmium on the
suppresso r cell activity may provide another explanation. 50 ppm of cadmium in
drinking water significantly reduces suppressor cell activity after 3 weeks
(Chowdhury et al 1987 - Malave and DeRuffino 1984).
Natural-killer cell activity was also studied. Natural-killer cells are a
heterogeneo us group of large granular lymphocytes that manifest spontaneo us
cytotoxicity against a variety of target cells without prior sensitization. In the present
study. cadmium significantly reduced natural-killer cell activity in mice at 4 hours.
This is in agreement with Chowohu rv and Chandra (1987) who also used the same
dose of cadmium treatment and observed a tendency for reduced NK activity at 4
hour5 and a larger reduction at 12 hours. Natural-killer cells recognize and lyse a
wide variety 01 tumour cells and other cell lines in vitro. Glycoprctelus on the surface
of the target cells are important for recognition by putative NK cell recepto rs. After
lysis 01 the target cell. the killer cell survives the encounter and proceeds to kill
aqain (Young and Cohn 1988). Reduction of NK activity in cadmium-treated animals
may be due to decreased total numbers of NK cells (Chowdhury and Chandra
1989). as animals failed to increase NK activity between 4 - t 2 hours. It is also
possible that reduced NK activity may be due to cadmium-induced inhibition of
calcium uptake by epithelial cells (Verbost et at 1987) as the process of target cell
lysis by NK cells occurs by Ca2 + dependent mechanisms.
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6.2 Effect of zinc deficiency on the immune system 01mice:
In the present study. the effect 01 dietary zinc defICiency on the immune
system 01young adult mice was investigated. Mice were maintained on a low zinc
diet (1 ppm) for 4 weeks. Animals started 10 shed hair from all over the bod y
especially the t~il by the encl altha lourth week. Zinc at a concentration of 1 ppm
in the diet for 4 weeks did not alter weight of the mice and that of different orqans
It also d id not alter lymphocyte counts in the blood, thymllS and spleen. Howeves,
there was a tendency for weight reduction at the end 01the fourth week, when the
treatment was discontinued. Fraker, et al (1987) reported a 26"" reduction of body
weight as well as marked reduct ion 01 thymus weiqht and splenic lymphocyte
number. This differences may be due to the form of diet provided as Ihe powdered
form is more rapidly absorbed than the pellet form. wilh more pronounced effects
It may also be straln dependent, as in Ihe present study C57BL/6 mice were used
while Fraker's study used differenl strains of mice named N :::NIH.
Loss of appetite is one of the first signs of zinc deficiency and occurs raJlidly
arter introduction of zinc-restricted diet (Chester and Ouarterman. 1970). The rate
of food consumption in the present study did not change lor 3 weeks. However in
the fourth week of feecJing a low zinc diet. the mice started to lose their appetite. It
was also noted by Hoaldley and Cousins (1985) that zinc depletion diel not
markedly depress load consumption.
Thymus of animals fed a low zinc diet showed moderate lymphoid cellular
degeneration on electron microscopy with more pronounced effect in the cortex
than the medulla. There was loss 01 mitochondria. cytoplasmic matrix and
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fragmentation of the cytoplasm in the interepithelial space . In 1985, Chandra
reported rapid ..~nd marked arroonv of the thymus and paucity of the co rtical
lymphoid cells in zinc deficient animals. It is possible that zinc protects cells (rom
injury by stabilizing cyroplasmlc mtcrotubules. cell surface membrane morphology,
calcium flow across these membranes and inhibiting calmodu lin function (Mara and
Bomee . 1979).
In the electron microscopic pictures of thymus , count ing the number of
cor tical epithel ial ceUsof animals treated with a low zinc d iet and comp aring them
with those of control ones with the same magni fication, the number of cells were
found to be reduced in the termer. However, the number and morphology of
medullary cells were normal. Also the total T-Iymphocyte count in the spleen was
normal. It is poss ible that the normal number of Iym,.: 'laid cells in tne medulia
compensated the moderately reduced number 01 cells in the cortex with resu ltant
normal total T' lympnocyte count.
Direct (lg M) and indirect (lgG) plaque forming cell responses were
sig nificantly reduced in mice treated with zinc-deficient diets. These observ ation s are
in agreemen t with Chandra and Au (1980) Fraker, et al (1987), Chandra and Puri
(19S5). lgM and IgG plaque-tcrrnlnq cell responses after SRSGS are injected during
a course 01 zinc deficiency is relatively poo r. A possibility Is that a state of zinc
deficiency migh t stimulate more immature Beene to accumulate in the spleen
bearing high amounts of surface IgM and IgG (Fraker et aI1 987). Or, it may be that
zinc defici ency could alter member responses already in force.
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For lurther invest igat ion 01 the enec t of z,rlC del lCiency on the iIllll"'''''
sys tem, T-cen subs !'!ts (helper and suppressor) and p rollff!fativ!'!response of spee o
ce lls to T-cel mitogen (phytohema ggl utinin · PHAI were~1'90"lled. Atter -l week s
of tre atment with zinc -d!'!flcien t di!'!t, roce showed sign lhcant red uc tion s ir' thi'
number s of bot h T·eeRecoeers (he lpElfj ind uce r Md suppr es SOfi cyto tox ic l . The se
obs ervations are in agreemant with Pekarek , et al (19 79). Fernandes. at aI ( 19791.
Frake r et al (1982) and Ch andra and Dayton (1982). Zinc is requ ired tor both
deo xyrib onu cleic acid (DNA) and rib on ucleic acid (ANA) synthesis. Zinc oeucteocv
in an imals impairs the incorporation 01 lab elled thym icrine into DNA , It is also
po ssible that the reduct ion if' DNA synthes is lTllly b e o.eto oec-eoseo ACtivity of
deoxy!hymidine kinas e (Prasad and Ot eoeas 1974 ). Recen tly, zinc ltn gef moll !s
have been demonstrated in eec renet DNA (Nagar e r aI 1986) sugg estnlQ a cruci~
role of zinc in DNA synthesis and cel l multiphc ;ltlOrt.
The pr~erative respons e of the spleen cea 10 T-ceu mtogen (PHAJ was
significan tly reduced In miCe trealed with zinC-deflciPnt diet . The un iqu e sens itivity
of the thy mus to zinc· deficiency with a resultan t decrease in the num be r and
proliferative respon se 01sp leen ceas to t- een mltog ens may be expla ined p arti<lly
by the enzy me leucoc yte lermin3 1 deo xynu cleOtidy l ueoereraee (Td T) which is
p resent in large qua ntities in early stages 01 thymocy te oeerenueuon . In p rotein
energy malnu trition (in which d ifferen t nutr ients including Zinc are deficient ), mymc
hor mone activity is redu ced (Chandra 1982) with resultant maturati on detect s In
thym ic lymphoc ytes , gre ater prop orti ons of immature (001) ce lls with increased level
01 l efT enzy me (Chandra 1980) and de creas ed lu lly dlflcrentia:ed T-cens. Effect of
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zinc deficiency on various hormones such as growth hormone might be another
poss ib.lty that requires lurther investigations. Further evidence lor the critica: role
01 zinc in norma l r -cen function is pr ovided by the ettects of zinc deficiency on
delayed-type hyperse nsitivity resporwes . In children with acrodermatitis
enteropathiea, these responses are impaired and are restored to normal after
several weeks of zinc therapy (Chandr'" 1980). Fraker, et al (1982) dem onst rated
.ower DTH responses in zinc·deficient mice who were subseque ntly sensitized with
dinitro fluorbenzene. Similar observations helve been reported in Down's synd rome
(Bjorkslen et al t 980) and prolonged twoereumemeuon with inadequate zinc intake
(Oleske et et. 1979).
Natural -killer cell activity is an impo rtant aspect of the immune response lor
protec tion ag ainst early phases of infections and tumours Mice treated with zinc-
delicient diels for 4 weeks showed a significant recucrton 01NK ceaactivity . This is
in ag reement with Chandra and Puri (1985) and Fraker. at al(1985) who eisc used
young adult mice fed with zinC-defICient diets . It is poss ible that reduced NK cea
activity is due to disturb ances in the zinc-calcium relationship. Zinc appears to play
a role in regul ating the IlflC tion 01membrane proteins and its deficienc y affects cell
mc rotcbules and microfilamenls (Brewer et al 1979). Lysis of the target cell by
natura l-killer cells appears to be a calcium dependent mechanism by whic h release
of the extracellular gran ules (perforin or cytol ysin) occurs into the space between
the two cells (Young and Cohn 1988).
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6.3 Effect of cadmium administration on the immune systenl of zinc-deficient mice
Cadmium and zinc have several phystochemtcel similarities. CAdmium is a
nonessentia l toxic metal. However, zinc is an essential element that counteracts a
number of the toxic effects of cadmium (Gunn et AI 1963). In ttus study, the effect
of a relatively low dose at cadmium on the immune system or aoc- deucen t mice
was Investigated. In addition. the effect of zinc aonuutsuauon arter cessatton or
trealment was observed. Treatment of mice with cadmium ancr zlnc-oencen t or
zinc-adequate diets did not affect the qeneral health. weiqht of the mice. weight 01
the different organs or lymphocyte counts in the spleen and thymus. However. nte
lymphoc yte counts of blood (collected form the right atrium or the heart! were
significantly decreased in mice ireateo with emc-oencrentdiet and in those given
cadmium for 3 weeks rollowing 4 weeks of zinc -deficient diet. Concurrent
administration of a moderate amount of zinc prevented the cacnnlum-lnduced
reduction in lymphocy te number. Lymphocyte stimulation response to PHA mitogen
was significantly reduced in mice treated with zinc-deficient diet IN 4 weeks
However. concur rent administration at cadmium tor 3 weeks compensated this
reducti on with no significant differences from the non-treated ccntrots. Zinc
administration did not affect lymphocyte stimulation response and mice treated with
cadmium and zinc had values comparable with Ihe control group.
It is possible that low zinc intake potentiate higher cadmium absorpt ion and
retention (Campbell et al. 1978). Dietary zinc status is also a controlling factor lor
metallothionein gene expression in the intestine (Menard et a11981) and Ihe liver
(McCormick et at 1981). Hence, in a state of zinc deficiency, metauottuonem
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synthesis decreases with subsequent decrease of metallothionein bound cadmium
and increased non -bound toxic cadmium.
Direct (19M)and indirect (lgG) plaque forming cells decreased significantly
in mice treated with zinc-deficient diet. Concurrent caornlurn administration tended
10 increase praque-rorrninq cell numbers . However, zinc administration prevented
that increase. Mice treated with zinc and cadm ium together demonstra ted the
antagoniz ing effect of both metals with values similar to the non-treated controls.
These observa tions are in agreement with those of Malave and De Auffino (1984)
who repo rted an increase in the IgM antibody response after treatment with 50 ppm
cadmium. Zinc administrat ion (50 ppm) was seen to oreventtnet increase. However.
Chowdhury et at (1987) used the same low dose of cadmium, and demonstrated
increases in primary and secondary antibody response which were prevented by
large doses of zinc (500 ppm). Meanwhile, Shippee, et al (1983) did not obse rve
any protective effect of zinc on cadmium induced alteration of immune responses.
It is possible that large doses of cadmium when delivered by injection. produced
irreversib le toxicity to the immune cells, in contrast to small oral doses that caused
temporary alteration of the immune funct ion with gradual recovery after cessation
of treatment.
It was also demonstrated in this study that an important step where the
enteqoniem between cadmium and zinc occu rred was at lhe level of T-cell subse ts.
Treatment with zinc-deficient diet significantly reduced the number of helper/ inducer
and suppressor/cytotoxic cells. However, concur rent administration 01 cadm ium
caused more reduction of both subsets . Zlnc administration prevented the reduction
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of helper (CD4 +) cells and tended to prevent that 01suppressor cells (CDS -t ) but
the number of suppressor was still significantly lower than the non-treated controls.
The CD4 +j CDS+ ratio which reflects the i1nmunoregulatory balance, increased
significantly after treatment with zinc-deficient diet and cadmium. However, mice
treated with zinc and cadmium together showed total number of T-cell subsets and
ratio to be cornpcrable with the non-treated controls.
Chowdhury, et at (1987) demonstrated cadmium-induced reduct ion of
suppressor cell number , as well as an increased CD4 + j CDS+ ratio with 50 ppm
cadmium in drinking water.
Zinc deficiency decrease s the activity of zinc-containing DNA polymerase with
resultant decrease of the DNA content of the thymus (Ku et al 1970). This wou ld
affect growt h, division and differentiation of T-Iymphocytes.
When the suppressive effectsof zinc -deficiency and cadmium werecombinecl
together they dramatically affected the numbers 01the T-cell subsets and rauo. This
was prob ably due to interactions between the two metals as cadmium treatment
alone altered T-cell subsets and zinc-deficiency alone also caused similar alterations .
but excess zinc did not affect 'l -cel' subsets or ratio. This observation might also
confirm that zinc -deficiency potentiates cadm ium retention and toxicity.
Natural-killer cell activity in a a-hour assay was significantly depressed atter
treatment with zinc-deficient diet. Concurrent cadmium administration caused a
greater depression. Zinc administ ration tended to prevent the suppress ion induced
by zinc-d eficiency and cadmium, but the act ivity was still significantly lower than in
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the non-t reated controls. Mice given zinc and cadm ium together, had NK activity
co mparable to that of the non-treated contro ls
Chowdhury, et al (1987) demonstrated dec reased NK celt activity in a 4-
ho ur assay and an increase in mean target cetl lysis between 4 and 12 hours with
cadm ium treatme nt. It is possible that the blochernlca' interaction of cadmium and
zinc and their relationship with calcium is responsible for suppression of NK activity.
Young and Cohn (1988) p roposed that lysis of the target celt by NK cell appea rs
to be a Ca +-dependen t mechanism . Zinc-deficiency has been indicated to lncreeee
cadmium absorp tion (Campbell et at 1978); cadmium has an inhibitory effect on
calcium absorption from the gastro intestinal tract (Gruden 1977 • Chertok et al
1981) as it directly causes physical and subsequently functional damage to the gut
epithelial celts.
6 .4 Cadm ium and zinc in the kidney
As might be expected , caorr.orn treated mice had significan tly high cadmium
con centrations in the kidney. How ever, after cessation of treatment and probably
du e to the long hatf life of cadmium , its concentra tions were still significantly hig her
tha n in tile non-treated controls. Similar observations were reported I::{ Borgman.
et al in 1986 and Chowdhu ry et al in 1987. Cadmium concentrations in the kidney
tended to increase in animals receiving zinc-deficient diet. Concurrent cadmium
treatment increased its levels further , reaching a statistically significant difference.
Even after cessation of treatment, the levels were significantly higher than the non-
tt eeted controls. This is in agreement with Tendon and Khandelwa ! (1987) who
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noted increased deposit ion of cadmium in kidneys of zinc-deficient rats and higher
concentrations after concurrent cadmium treatment.
Zinc administration (50 ppm) tended to decrease cadmiu m con centrations.
This is similar to findings reported by Campbell , et at in 1978 find Petering, et al in
1971.
Animals treated with a zmc-deuctent diet for 4 weeks. showed a tendency for
decreased zinc concentrations in the kidney. However, concurrent cadmium
treatment tended to increase zinc concentration. On the other hand, animals treated
with cadmium only also showed increased zinc concentrations. Similar observauone
were noted by Tandon and Khandelwal (1987).
Administration of zinc slqnificantly increased its concentrations in tile kidney
(Table 5-17). However, a tendency for increased zlr.c concentrations was observed
in all the groups after cessation of treatment. Cadmium is absorbed from the
gastrointestinal tract, then incorporated with meteuotho nem in the liver, released to
the circulation, filtered through the glomeruli, reabsorbed from the prox imal tubul es
and excreted mainly in urine (KostiaI1986). Zinc is absorbed in the intestine, carried
to the portal circulation where it is bound to albumin, then secreted back into the
intestine and excreted in feces (Bunker at al 1982).
It also appea rs that during treatment with cadmium, there is a continuous
incorporat ion with metallothio nein in the liver, whil .~ after cessation of treatment,
there is gradual loss of cadmium from the liver and continuous uptake by the kidney
(Friberg 1984). This effect was greater in the proximal tubules, as in the present
study, electron microscopy showed increased mitochondria and distor ted cisternae
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in the proximal tubular cells. The mechanisms by which cadm ium damages the
proxima l tubules may originate in the reabsorption of cadmium-me tallothionein from
the tub ular lumen or a direct effect of toxic ncn-rnetencthtonein - unbound cadmium.
Mice treated with zinc-deficient diets did not show any ultrastructural changes in the
kidney.
6.5 Cadmium and zinc interaction:
Zinc and cadm ium have striking physical and chemical similarities. They both
belong to group II of the Periodic Table. Zinc is an essential element, however,
cadm ium is a toxic metal. Toxicity of cadmium can be prevented or treated by zinc.
Various reports have tried to explain the mechanism(s) behind cadmium and zinc
interaction and the effects on the mmone system.
MetaHothionein has been considered a key compo nent in the cellular
detox ification system fer cad mium and zinc. Three forms have been identified, one
bind ing equmotar amounts of cadmium and zinc, a second binding mainly zinc and
a third binding mainly cadmium (Elinder. 1977). It is known that rnetellcmtoneln
synthesis is regulated by heavy metals such as cadm ium, cop per, zinc and mercury.
It is possible that zinc deficiency causes reduced metalloth ionein synthesis,
especially the type that binds firmly to cadmium . As a result, levels of non-bo und
toxic cadmium are increased and concurrent cadmium treatment increases the
toxicity further. However, zinc administration may reverse this phenomenon.
Studies on experimental animals showed that cadmi um reduces the activity
of zinc dependent enzymes (Vallee and Ulmer 1972). It is: possible that the
competition between cadmium and zinc at cofactor sites in enzymes requiring zinc
- 101-
is responsible for the toxicity of cadmium. On the other hand, cadmium may
displace zinc from certain enzymes crueler lor natural killer cell activity. In tile
present study, treatment with a zinc-deficient diet tended to increase cadmium
concentrations in the kidney, and decrease NK activity. However, concurrent
cadmiur" treatment caused further suppression of NK C!ctivity and zinc
administration lended to prevent thisselectivesuppressiveeffect of cadmium on NK
activity. Suzuki and Chertan (1987) noted that pretreatment with zinc prevented the
cadmium-induced alterations in some enzymeactivities.
Another possibility is that zinc may interfere with cadmium metabolism. This
was hypothesized by Jones et.al., 1985 who reported Ihat zinc treatment, slowed
the cadmium distribution process, So in zinc deficiency cadmium migllt be
distributed in tissues more widely with resultant increased toxicity
6.6 Summary and conclusion:
In the present study, it was demonstrated thai zinc deficiency (1 ppm) tor 4
weeks, had a supp ressive effect on the Immune system. Concurrent cadmium
treatment at doses of 50 ppm in drinking water caused more alterations of the
immune cell function. General health of the mice, weight of ditterent organs or
lymphocyte counts in the spleen and thymus were not altered by either zinc.
deficient diet or cadmium treatment. The number of 't-een subsets (helper CD4 -I
and suppressor CDS+) and natural-killer cell aCfivltywere reduced. 19M and IgG
antibody production decreased with zinc deficiency and increased with cadmium
treatment. Zinc in oral doses of 50 ppm antagonized cadmium-induced
immunopathology.
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Kidney s were affected by cadmium treatment, as evidenced by ultrastructural
abn ormalities. However. a low zinc diet affected the electron microscopic
appe arance of the cortical area of the thymus but not the medulla. It is poss ible that
low zinc levels lor such short period s might be enough to be absorbed by different
tissues, but not released back to the circulation wtich may be exp lained by low
lymphocyte counts in the blood , but no t In th e spteen or thymus. Further
Investigations with longer lengths of zinc o enciency might prove this hypothe sis.
Results of this study demonstrated that symptoms of cadmium toxicity were
simila r to those of zinc deficiency, It Is possible that the cytotoxic eHects of cadmium
were partially due to conditional zinc deficiency inside the cells. Nevertheless, zinc
defi ciency might potentiate cadmium tox iC~y by direct interference wlth its
meta bolism or by Interference with metallothionein synthesis.
This study has focused attent ion all only a part 01 the immu ne system . It
would be worthwhile to test other specific and oco-ececnc respo nses such as
suppr essor cel activity, B-cells in the spleen. and i'lterleuk in-2. It would also be
helpful to inve stigate the effects of cadmium and Zinc defICiency on other organs
suc h as the liver and on other metals, such as calcium and copp er.
Finally, the ukimate testing of immunocom petence Is to examine the outcome
challenge following of zinc deficient animals with tumour implants and infectious
org anisms that are cleared by various host defence s such as listeria monocytosis,
Staphylococ cus aureus and Escherichia co li.
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